{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%%capture\n",
    "# !pip install unsloth\n",
    "# # Also get the latest nightly Unsloth!\n",
    "# !pip uninstall unsloth -y && pip install --upgrade --no-cache-dir --no-deps git+https://github.com/unslothai/unsloth.git"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ðŸ¦¥ Unsloth: Will patch your computer to enable 2x faster free finetuning.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-01-29 02:16:38.019279: I tensorflow/core/util/port.cc:153] oneDNN custom operations are on. You may see slightly different numerical results due to floating-point round-off errors from different computation orders. To turn them off, set the environment variable `TF_ENABLE_ONEDNN_OPTS=0`.\n",
      "2025-01-29 02:16:38.034855: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:477] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n",
      "WARNING: All log messages before absl::InitializeLog() is called are written to STDERR\n",
      "E0000 00:00:1738084598.052203  754731 cuda_dnn.cc:8310] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n",
      "E0000 00:00:1738084598.057443  754731 cuda_blas.cc:1418] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
      "2025-01-29 02:16:38.076363: I tensorflow/core/platform/cpu_feature_guard.cc:210] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n",
      "To enable the following instructions: AVX2 AVX512F AVX512_VNNI FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unsloth: OpenAI failed to import - ignoring for now.\n",
      "ðŸ¦¥ Unsloth Zoo will now patch everything to make training faster!\n",
      "==((====))==  Unsloth 2024.12.4: Fast Llama patching. Transformers:4.46.3.\n",
      "   \\\\   /|    GPU: NVIDIA A100-PCIE-40GB. Max memory: 39.394 GB. Platform: Linux.\n",
      "O^O/ \\_/ \\    Torch: 2.5.0+cu124. CUDA: 8.0. CUDA Toolkit: 12.4. Triton: 3.1.0\n",
      "\\        /    Bfloat16 = TRUE. FA [Xformers = 0.0.28.post2. FA2 = True]\n",
      " \"-____-\"     Free Apache license: http://github.com/unslothai/unsloth\n",
      "Unsloth: Fast downloading is enabled - ignore downloading bars which are red colored!\n"
     ]
    }
   ],
   "source": [
    "from unsloth import FastLanguageModel\n",
    "import torch\n",
    "max_seq_length = 2048 # Choose any! We auto support RoPE Scaling internally!\n",
    "dtype = None # None for auto detection. Float16 for Tesla T4, V100, Bfloat16 for Ampere+\n",
    "load_in_4bit = True # Use 4bit quantization to reduce memory usage. Can be False.\n",
    "\n",
    "# 4bit pre quantized models we support for 4x faster downloading + no OOMs.\n",
    "fourbit_models = [\n",
    "    \"unsloth/Meta-Llama-3.1-8B-bnb-4bit\",      # Llama-3.1 15 trillion tokens model 2x faster!\n",
    "    \"unsloth/Meta-Llama-3.1-8B-Instruct-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-70B-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-405B-bnb-4bit\",    # We also uploaded 4bit for 405b!\n",
    "    \"unsloth/Mistral-Nemo-Base-2407-bnb-4bit\", # New Mistral 12b 2x faster!\n",
    "    \"unsloth/Mistral-Nemo-Instruct-2407-bnb-4bit\",\n",
    "    \"unsloth/mistral-7b-v0.3-bnb-4bit\",        # Mistral v3 2x faster!\n",
    "    \"unsloth/mistral-7b-instruct-v0.3-bnb-4bit\",\n",
    "    \"unsloth/Phi-3.5-mini-instruct\",           # Phi-3.5 2x faster!\n",
    "    \"unsloth/Phi-3-medium-4k-instruct\",\n",
    "    \"unsloth/gemma-2-9b-bnb-4bit\",\n",
    "    \"unsloth/gemma-2-27b-bnb-4bit\",            # Gemma 2x faster!\n",
    "] # More models at https://huggingface.co/unsloth\n",
    "\n",
    "model, tokenizer = FastLanguageModel.from_pretrained(\n",
    "    model_name = \"unsloth/Meta-Llama-3.1-8B\",\n",
    "    max_seq_length = max_seq_length,\n",
    "    dtype = dtype,\n",
    "    load_in_4bit = load_in_4bit,\n",
    "    # token = \"hf_...\", # use one if using gated models like meta-llama/Llama-2-7b-hf\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Unsloth: Dropout = 0 is supported for fast patching. You are using dropout = 0.05.\n",
      "Unsloth will patch all other layers, except LoRA matrices, causing a performance hit.\n",
      "Unsloth 2024.12.4 patched 32 layers with 0 QKV layers, 0 O layers and 0 MLP layers.\n"
     ]
    }
   ],
   "source": [
    "model = FastLanguageModel.get_peft_model(\n",
    "    model,\n",
    "    r = 8, # Choose any number > 0 ! Suggested 8, 16, 32, 64, 128\n",
    "    # target_modules = [\"q_proj\", \"k_proj\", \"v_proj\", \"o_proj\",\n",
    "    #                  \"gate_proj\", \"up_proj\", \"down_proj\",],\n",
    "    target_modules = [\"q_proj\", \"k_proj\", \"v_proj\"],\n",
    "    lora_alpha = 16,\n",
    "    lora_dropout = 0.05, # Supports any, but = 0 is optimized\n",
    "    bias = \"none\",    # Supports any, but = \"none\" is optimized\n",
    "    # [NEW] \"unsloth\" uses 30% less VRAM, fits 2x larger batch sizes!\n",
    "    use_gradient_checkpointing = \"unsloth\", # True or \"unsloth\" for very long context\n",
    "    random_state = 3407,\n",
    "    use_rslora = False,  # We support rank stabilized LoRA\n",
    "    loftq_config = None, # And LoftQ\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
    "\n",
    "### Instruction:\n",
    "{}\n",
    "\n",
    "### Input:\n",
    "{}\n",
    "\n",
    "### Response:\n",
    "{}\"\"\"\n",
    "\n",
    "EOS_TOKEN = tokenizer.eos_token # Must add EOS_TOKEN\n",
    "def formatting_prompts_func(examples):\n",
    "    instructions = examples[\"instruction\"]\n",
    "    inputs       = examples[\"input\"]\n",
    "    outputs      = examples[\"output\"]\n",
    "    texts = []\n",
    "    for instruction, input, output in zip(instructions, inputs, outputs):\n",
    "        # Must add EOS_TOKEN, otherwise your generation will go on forever!\n",
    "        text = alpaca_prompt.format(instruction, input, output) + EOS_TOKEN\n",
    "        texts.append(text)\n",
    "    return { \"text\" : texts, }\n",
    "pass\n",
    "\n",
    "from datasets import load_dataset\n",
    "dataset = load_dataset(\"passionMan/diabetes_v9\", split = \"train\")\n",
    "dataset = dataset.map(formatting_prompts_func, batched = True,)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3cfacf30ed894286bb8359f5c6526c46",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/33937 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a9d13c8d022d4889bc318b9fd9aa92a9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map (num_proc=16):   0%|          | 0/33937 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from trl import SFTTrainer\n",
    "from transformers import TrainingArguments\n",
    "from unsloth import is_bfloat16_supported\n",
    "from datasets import Dataset, concatenate_datasets\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# ë¦¬ìŠ¤íŠ¸ í˜•íƒœì˜ datasetì„ Pandas DataFrameìœ¼ë¡œ ë³€í™˜\n",
    "dataset_df = pd.DataFrame(dataset)\n",
    "\n",
    "# ê¸´ ë°ì´í„°ì™€ ì§§ì€ ë°ì´í„° ë¶„ë¦¬\n",
    "long_data = dataset_df[dataset_df['dataset'].isin(['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal'])].reset_index(drop=True)  # ì¸ë±ìŠ¤ ì œê±°\n",
    "short_data = dataset_df[~dataset_df['dataset'].isin(['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal'])].reset_index(drop=True)  # ì¸ë±ìŠ¤ ì œê±°\n",
    "\n",
    "# ë°ì´í„°ì…‹ ìƒì„±\n",
    "long_dataset = Dataset.from_pandas(long_data)\n",
    "short_dataset = Dataset.from_pandas(short_data)\n",
    "\n",
    "# ë°ì´í„° ê²°í•©\n",
    "combined_dataset = concatenate_datasets([short_dataset, long_dataset])\n",
    "\n",
    "# ìƒ˜í”Œë§ ê°€ì¤‘ì¹˜ ì„¤ì •\n",
    "# Hugging Face Datasetì—ì„œ map í•¨ìˆ˜ê°€ dictë¥¼ ë°˜í™˜í•˜ë„ë¡ ìˆ˜ì •\n",
    "def compute_weights(example):\n",
    "    return {\"weight\": 0.25 if example['dataset'] in ['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal'] else 0.75}\n",
    "\n",
    "# map í•¨ìˆ˜ë¡œ ê°€ì¤‘ì¹˜ ë¦¬ìŠ¤íŠ¸ ìƒì„±\n",
    "weighted_dataset = combined_dataset.map(compute_weights)\n",
    "\n",
    "# ê°€ì¤‘ì¹˜ ì¶”ì¶œ ë° ì •ê·œí™”\n",
    "weights = np.array(weighted_dataset[\"weight\"])\n",
    "weights = weights / weights.sum()  # ê°€ì¤‘ì¹˜ í•©ì´ 1ì´ ë˜ë„ë¡ ì •ê·œí™”\n",
    "\n",
    "# ë°ì´í„° ìž¬ìƒ˜í”Œë§\n",
    "weighted_indices = np.random.choice(len(combined_dataset), size=len(combined_dataset), p=weights)\n",
    "resampled_dataset = combined_dataset.select(weighted_indices)\n",
    "\n",
    "# í•™ìŠµ ì„¤ì •\n",
    "trainer = SFTTrainer(\n",
    "    model=model,\n",
    "    tokenizer=tokenizer,\n",
    "    train_dataset=resampled_dataset,\n",
    "    dataset_text_field=\"text\",\n",
    "    max_seq_length=2048,  # ê¸´ ë°ì´í„°ë„ ì²˜ë¦¬ ê°€ëŠ¥í•˜ë„ë¡ ì„¤ì •\n",
    "    dataset_num_proc = 16,  # í˜„ìž¬ 2ì—ì„œ ì¦ê°€\n",
    "\n",
    "    args=TrainingArguments(\n",
    "        per_device_train_batch_size=32,\n",
    "        gradient_accumulation_steps=1,\n",
    "        warmup_steps=200,\n",
    "        num_train_epochs=3,  # 3 epochs ì„¤ì •\n",
    "        learning_rate=3e-5,  # ë‚®ì€ í•™ìŠµë¥ ë¡œ ê· í˜• ìœ ì§€\n",
    "        fp16=not is_bfloat16_supported(),\n",
    "        bf16=is_bfloat16_supported(),\n",
    "        optim=\"adamw_8bit\",\n",
    "        weight_decay = 0.01,\n",
    "        lr_scheduler_type = \"cosine\",\n",
    "        logging_steps=100,\n",
    "        seed=3407,\n",
    "        save_steps=200,\n",
    "        output_dir=\"outputs/weighted_sampling8\",\n",
    "        report_to=\"none\",\n",
    "    ),\n",
    ")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3cfacf30ed894286bb8359f5c6526c46",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/33937 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a9d13c8d022d4889bc318b9fd9aa92a9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map (num_proc=16):   0%|          | 0/33937 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from trl import SFTTrainer\n",
    "from transformers import TrainingArguments\n",
    "from unsloth import is_bfloat16_supported\n",
    "from datasets import Dataset, concatenate_datasets\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# ë¦¬ìŠ¤íŠ¸ í˜•íƒœì˜ datasetì„ Pandas DataFrameìœ¼ë¡œ ë³€í™˜\n",
    "dataset_df = pd.DataFrame(dataset)\n",
    "\n",
    "# ê¸´ ë°ì´í„°ì™€ ì§§ì€ ë°ì´í„° ë¶„ë¦¬\n",
    "long_data = dataset_df[dataset_df['dataset'].isin(['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal'])].reset_index(drop=True)  # ì¸ë±ìŠ¤ ì œê±°\n",
    "short_data = dataset_df[~dataset_df['dataset'].isin(['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal'])].reset_index(drop=True)  # ì¸ë±ìŠ¤ ì œê±°\n",
    "\n",
    "# ë°ì´í„°ì…‹ ìƒì„±\n",
    "long_dataset = Dataset.from_pandas(long_data)\n",
    "short_dataset = Dataset.from_pandas(short_data)\n",
    "\n",
    "# ë°ì´í„° ê²°í•©\n",
    "combined_dataset = concatenate_datasets([short_dataset, long_dataset])\n",
    "\n",
    "# ìƒ˜í”Œë§ ê°€ì¤‘ì¹˜ ì„¤ì •\n",
    "# Hugging Face Datasetì—ì„œ map í•¨ìˆ˜ê°€ dictë¥¼ ë°˜í™˜í•˜ë„ë¡ ìˆ˜ì •\n",
    "def compute_weights(example):\n",
    "    return {\"weight\": 0.25 if example['dataset'] in ['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal'] else 0.75}\n",
    "\n",
    "# map í•¨ìˆ˜ë¡œ ê°€ì¤‘ì¹˜ ë¦¬ìŠ¤íŠ¸ ìƒì„±\n",
    "weighted_dataset = combined_dataset.map(compute_weights)\n",
    "\n",
    "# ê°€ì¤‘ì¹˜ ì¶”ì¶œ ë° ì •ê·œí™”\n",
    "weights = np.array(weighted_dataset[\"weight\"])\n",
    "weights = weights / weights.sum()  # ê°€ì¤‘ì¹˜ í•©ì´ 1ì´ ë˜ë„ë¡ ì •ê·œí™”\n",
    "\n",
    "# ë°ì´í„° ìž¬ìƒ˜í”Œë§\n",
    "weighted_indices = np.random.choice(len(combined_dataset), size=len(combined_dataset), p=weights)\n",
    "resampled_dataset = combined_dataset.select(weighted_indices)\n",
    "\n",
    "# í•™ìŠµ ì„¤ì •\n",
    "trainer = SFTTrainer(\n",
    "    model=model,\n",
    "    tokenizer=tokenizer,\n",
    "    train_dataset=resampled_dataset,\n",
    "    dataset_text_field=\"text\",\n",
    "    max_seq_length=2048,  # ê¸´ ë°ì´í„°ë„ ì²˜ë¦¬ ê°€ëŠ¥í•˜ë„ë¡ ì„¤ì •\n",
    "    dataset_num_proc = 16,  # í˜„ìž¬ 2ì—ì„œ ì¦ê°€\n",
    "\n",
    "    args=TrainingArguments(\n",
    "        per_device_train_batch_size=32,\n",
    "        gradient_accumulation_steps=1,\n",
    "        warmup_steps=200,\n",
    "        num_train_epochs=3,  # 3 epochs ì„¤ì •\n",
    "        learning_rate=3e-5,  # ë‚®ì€ í•™ìŠµë¥ ë¡œ ê· í˜• ìœ ì§€\n",
    "        fp16=not is_bfloat16_supported(),\n",
    "        bf16=is_bfloat16_supported(),\n",
    "        optim=\"adamw_8bit\",\n",
    "        weight_decay = 0.01,\n",
    "        lr_scheduler_type = \"cosine\",\n",
    "        logging_steps=100,\n",
    "        seed=3407,\n",
    "        save_steps=200,\n",
    "        output_dir=\"outputs/weighted_sampling8\",\n",
    "        report_to=\"none\",\n",
    "    ),\n",
    ")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Dataset({\n",
       "    features: ['dataset', 'split_data', 'task', 'instruction', 'input', 'output', '__index_level_0__', 'text'],\n",
       "    num_rows: 33937\n",
       "})"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "resampled_dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "==((====))==  Unsloth - 2x faster free finetuning | Num GPUs = 1\n",
      "   \\\\   /|    Num examples = 33,937 | Num Epochs = 3\n",
      "O^O/ \\_/ \\    Batch size per device = 32 | Gradient Accumulation steps = 1\n",
      "\\        /    Total batch size = 32 | Total steps = 3,183\n",
      " \"-____-\"     Number of trainable parameters = 4,718,592\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "    <div>\n",
       "      \n",
       "      <progress value='22' max='3183' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
       "      [  22/3183 03:52 < 10:11:39, 0.09 it/s, Epoch 0.02/3]\n",
       "    </div>\n",
       "    <table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       " <tr style=\"text-align: left;\">\n",
       "      <th>Step</th>\n",
       "      <th>Training Loss</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table><p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[5], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m trainer_stats \u001b[38;5;241m=\u001b[39m \u001b[43mtrainer\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mtrain\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m<string>:157\u001b[0m, in \u001b[0;36mtrain\u001b[0;34m(self, resume_from_checkpoint, trial, ignore_keys_for_eval, **kwargs)\u001b[0m\n",
      "File \u001b[0;32m<string>:385\u001b[0m, in \u001b[0;36m_fast_inner_training_loop\u001b[0;34m(self, batch_size, args, resume_from_checkpoint, trial, ignore_keys_for_eval)\u001b[0m\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "trainer_stats = trainer.train()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "## inference"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "from unsloth import FastLanguageModel\n",
    "import torch\n",
    "max_seq_length = 2048 # Choose any! We auto support RoPE Scaling internally!\n",
    "dtype = None # None for auto detection. Float16 for Tesla T4, V100, Bfloat16 for Ampere+\n",
    "load_in_4bit = True # Use 4bit quantization to reduce memory usage. Can be False.\n",
    "\n",
    "# 4bit pre quantized models we support for 4x faster downloading + no OOMs.\n",
    "fourbit_models = [\n",
    "    \"unsloth/Meta-Llama-3.1-8B-bnb-4bit\",      # Llama-3.1 15 trillion tokens model 2x faster!\n",
    "    \"unsloth/Meta-Llama-3.1-8B-Instruct-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-70B-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-405B-bnb-4bit\",    # We also uploaded 4bit for 405b!\n",
    "    \"unsloth/Mistral-Nemo-Base-2407-bnb-4bit\", # New Mistral 12b 2x faster!\n",
    "    \"unsloth/Mistral-Nemo-Instruct-2407-bnb-4bit\",\n",
    "    \"unsloth/mistral-7b-v0.3-bnb-4bit\",        # Mistral v3 2x faster!\n",
    "    \"unsloth/mistral-7b-instruct-v0.3-bnb-4bit\",\n",
    "    \"unsloth/Phi-3.5-mini-instruct\",           # Phi-3.5 2x faster!\n",
    "    \"unsloth/Phi-3-medium-4k-instruct\",\n",
    "    \"unsloth/gemma-2-9b-bnb-4bit\",\n",
    "    \"unsloth/gemma-2-27b-bnb-4bit\",            # Gemma 2x faster!\n",
    "] # More models at https://huggingface.co/unsloth\n",
    "\n",
    "model, tokenizer = FastLanguageModel.from_pretrained(\n",
    "    model_name = \"/data/jaesung/llm_for_diabetes/src/model/outputs/checkpoint-3214\",\n",
    "    max_seq_length = max_seq_length,\n",
    "    dtype = dtype,\n",
    "    load_in_4bit = load_in_4bit,\n",
    "    # token = \"hf_...\", # use one if using gated models like meta-llama/Llama-2-7b-hf\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<|begin_of_text|>Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
      "\n",
      "### Instruction:\n",
      "Recommend a daily diet that includes a specific ingredient.\n",
      "\n",
      "### Input:\n",
      "Create a diet that includes baby bok choy(roots trimmed and roughly chopped).\n",
      "\n",
      "### Response:\n",
      "{\"Breakfast\": \"Pumpkin-Banana Muffins\", \"Lunch\": \"Turkey Meatball \\u201cWonton\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}<|end_of_text|>\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "FastLanguageModel.for_inference(model) # Enable native 2x faster inference\n",
    "\n",
    "# alpaca_prompt = You MUST copy from above!\n",
    "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
    "\n",
    "### Instruction:\n",
    "{}\n",
    "\n",
    "### Input:\n",
    "{}\n",
    "\n",
    "### Response:\n",
    "{}\"\"\"\n",
    "\n",
    "\n",
    "inputs = tokenizer(\n",
    "[\n",
    "    alpaca_prompt.format(\n",
    "        \"Recommend a daily diet that includes a specific ingredient.\",\n",
    "\n",
    "        \"Create a diet that includes baby bok choy(roots trimmed and roughly chopped).\",\n",
    "\n",
    "        \"\", # output - leave this blank for generation!\n",
    "    )\n",
    "], return_tensors = \"pt\").to(\"cuda\")\n",
    "\n",
    "from transformers import TextStreamer\n",
    "text_streamer = TextStreamer(tokenizer)\n",
    "_ = model.generate(**inputs, streamer = text_streamer, max_new_tokens = 2048)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Task: ie_extract_relation, Sampled: 50\n",
      "{'dataset': 'biorel', 'split_data': 'test', 'task': 'ie_extract_relation', 'instruction': 'Extract exactly two biomedical entity pairs (head and tail entities) from the following text.', 'input': 'in vivo measurements of sulcal plaque ph in rats after topical applications of xylitol , sorbitol , glucose , sucrose , and sucrose plus 53 mm sodium fluoride .', 'output': 'plaque, sodium fluoride', '__index_level_0__': 29568}\n",
      "{'dataset': 'biorel', 'split_data': 'test', 'task': 'ie_extract_relation', 'instruction': 'Extract exactly two biomedical entity pairs (head and tail entities) from the following text.', 'input': 'in physiologically controlled puppies ( bp 66 +/- 3 mm hg ; pao2 71 +/- 2 mm hg ; paco2 35 mm hg , ph 7.39 +/- 0.04 ; hematocrit 39 +/- 2 % ) , the 2-deoxyglucose ( 2-dg ) autoradiographs and quantitative data reveal a characteristic pattern of regional energy metabolic needs in the normal newborn brain : highest glucose consumption values are found in brain stem nuclei ( inferior olivary nucleus 19 +/- 4 mumol/100 g/min ; vestibular nucleus 26 +/- 5 ; red nucleus 15 +/- 2 ) and in selected deep cerebral structures ( subthalamic nucleus 18 +/- 4 ; ventrolateral thalamic nucleus 12 +/- 2 , ... )', 'output': 'brain, vestibular nucleus', '__index_level_0__': 29630}\n",
      "{'dataset': 'biorel', 'split_data': 'test', 'task': 'ie_extract_relation', 'instruction': 'Extract exactly two biomedical entity pairs (head and tail entities) from the following text.', 'input': 'the tinu syndrome is isolated from other forms of tubulo interstitial nephritis by the particular symptomatology and course : the nephropathy is almost always reversible , the uveitis tends towards relapses .', 'output': 'tinu, syndrome', '__index_level_0__': 29553}\n",
      "{'dataset': 'biorel', 'split_data': 'test', 'task': 'ie_extract_relation', 'instruction': 'Extract exactly two biomedical entity pairs (head and tail entities) from the following text.', 'input': 'dietary change among adult dogrib indians of the northwest territories , canada , is examined in conjunction with differences in mean glucose levels among more acculturated-less acculturated settlements .', 'output': 'northwest territories, canada', '__index_level_0__': 29578}\n",
      "{'dataset': 'biorel', 'split_data': 'test', 'task': 'ie_extract_relation', 'instruction': 'Extract exactly two biomedical entity pairs (head and tail entities) from the following text.', 'input': 'in pima indians aged 50-79 years , the incidence of fatal chd was less than half that found in the framingham population after controlling for age , sex , and diabetes ( incidence rate ratio , 0.4 ; 95 % confidence interval , 0.2-0.7 ) .', 'output': 'the, chd', '__index_level_0__': 29590}\n",
      "Task: daily_diets, Sampled: 50\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet based on the given nutritional goals.', 'input': 'Ensure the daily carbohydrate intake does not exceed 65.0g, protein intake is at least 55.0g, and fat intake does not exceed 12.0g.', 'output': '{\"Breakfast\": \"Sugar Free Yogurt Parfait with Fresh Berries\", \"Lunch\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}', '__index_level_0__': 33240}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet based on the given nutritional goals.', 'input': 'Ensure the daily carbohydrate intake does not exceed 66.0g, protein intake is at least 38.0g, and fat intake does not exceed 22.0g.', 'output': '{\"Breakfast\": \"Turkey Sausage and Egg Casserole\", \"Lunch\": \"Quinoa Dessert Pudding\", \"Dinner\": \"Beef & Broccoli Stir Fry\"}', '__index_level_0__': 32355}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet that includes a specific ingredient.', 'input': 'Create a diet that includes avocado(medium diced).', 'output': '{\"Breakfast\": \"Watermelon Quinoa Salad\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Vegetarian Kale Pasta\"}', '__index_level_0__': 32273}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet that includes a specific ingredient.', 'input': 'Create a diet that includes all-purpose flour or whole-wheat pastry flour.', 'output': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Sausage and Egg Casserole\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}', '__index_level_0__': 33183}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet based on the given nutritional goals.', 'input': 'Ensure the daily carbohydrate intake does not exceed 47.0g, protein intake is at least 31.0g, and fat intake does not exceed 12.0g.', 'output': '{\"Breakfast\": \"Almost Smooth Salsa\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}', '__index_level_0__': 33165}\n",
      "Task: alternative_diet, Sampled: 50\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Popcorn, ready-to-eat packaged, low sodium', 'output': 'Mexican Black Bean Soup is recommended. The reason is Mexican Black Bean Soup complements Popcorn by providing a higher protein content, more fiber, and additional nutrients like potassium and phosphorus. However, individuals should be cautious of the sodium content in the soup, which may not be suitable for those on a low-sodium diet.', '__index_level_0__': 34121}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Coffee, Latte, with non-dairy milk', 'output': \"Chopped Black Bean Chicken Salad is recommended. The reason is 'Chopped Black Bean Chicken Salad' complements 'Coffee, Latte, with non-dairy milk' as it provides a good source of protein, fiber, and essential vitamins and minerals that are lacking in the latte. However, caution should be taken as the salad may contain added sugars or high sodium content, which could be detrimental to overall health if consumed in excess.\", '__index_level_0__': 33863}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Tuna salad, made with mayonnaise', 'output': 'Caprese Kabobs is recommended. The reason is Caprese Kabobs complement Tuna salad, made with mayonnaise because they are low in carbohydrates, packed with flavor, and provide a good source of potassium and protein. However, as cautionary points, Caprese Kabobs may be higher in saturated fat due to the use of cheese and may not provide as much fiber as needed to address certain deficiencies.', '__index_level_0__': 33451}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Salmon, baked or broiled, made with oil', 'output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Salmon, baked or broiled, made with oil' as it provides a good source of protein, potassium, and dietary fiber, which are lacking in the consumed food. However, caution should be taken with the sodium content in the sausage, especially for individuals monitoring their sodium intake.\", '__index_level_0__': 34230}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Coconut oil', 'output': \"Budget-Friendly Veggie Burgers with Mango Slaw is recommended. The reason is 'Budget-Friendly Veggie Burgers with Mango Slaw' complements 'Coconut oil' by providing protein, fiber, potassium, and other essential nutrients that are lacking in coconut oil. However, caution should be taken with the sodium content in the dish, as it may be high for some individuals.\", '__index_level_0__': 33758}\n",
      "Task: qa_objective_1, Sampled: 50\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'An elderly patient is receiving a blood transfusion for anemia due to myelodysplastic syndrome (MDS). He was diagnosed with MDS 2 years ago and over the past 6 months has required blood transfusions every 6 weeks for symptomatic anemia. His past medical history also includes hypertension, Type 2 diabetes, and coronary artery disease. Halfway through the transfusion of the second unit of packed red blood cells he develops tachypnea, lumbar pain, tachycardia, and nausea. Which of the following is the most likely explanation? Please select one of the following: A) anxiety, B) fluid overload, C) hemolysis, D) pulmonary embolism.', 'output': 'C) hemolysis', '__index_level_0__': 29847}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'Autosomal varient of nephrogenic diabetes insipidus is due to defect in Please select one of the following: A) Aquaporin 2, B) Angiotensin I receptor, C) Angiotensin II receptor, D) VIP receptors.', 'output': 'A) Aquaporin 2', '__index_level_0__': 29927}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'False about Charcots joint in diabetes mellitus is Please select one of the following: A) Limitation of movements with bracing, B) Ahrodesis, C) Total ankle replacemnt, D) Ahrocentesis.', 'output': 'C) Total ankle replacemnt', '__index_level_0__': 29962}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'All of the following are true about  glucose transport in kidney except Please select one of the following: A) Sodium Glucose symport is an example of  primary active transport, B) GLUT - 2 receptors are present along basolaterl membrane, C) Defective SGLT - 2 leads to isolated renal glycosuria, D) Transport maximum for glucose is 2 oomg / dL.', 'output': 'A) Sodium Glucose symport is an example of  primary active transport', '__index_level_0__': 29862}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'Hypoglycemia in neonates occurs in blood glucose less than Please select one of the following: A) 20 mg%, B) 40 mg%, C) 60 mg%, D) 10mg%.', 'output': 'B) 40 mg%', '__index_level_0__': 29896}\n",
      "Task: qa_objective_3, Sampled: 50\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is admission blood glucose an independent predictive factor for hospital mortality in polytraumatised patients? Context: The goal of this study was to analyse a possible association of admission blood glucose with hospital mortality of polytraumatised patients and to develop an outcome prediction model for this patient group. The outcome of adult polytraumatised patients admitted to the University Hospital of Berne, Switzerland, between 2002 and 2004 with an ISS > or = 17, and more than one severely injured organ system was retrospectively analysed. The inclusion criteria were met by 555 patients, of which 108 (19.5%) died. Hyperglycaemia proved to be an independent predictor for hospital mortality (P < 0.0001), following multiple regression analysis. After inclusion of admission blood glucose, the calculated mortality prediction model performed better than currently described models (P < 0.0001, AUC 0.924).', 'output': 'yes', '__index_level_0__': 30345}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is nonarteritic anterior ischemic optic neuropathy associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene? Context: To evaluate the association between platelet glycoprotein polymorphisms and the risks of single and second eye involvement with nonarteritic anterior ischemic optic neuropathy (NAION). Case-control study. Ninety-two consecutive patients with NAION, 26 of whom had second eye involvement, and 145 controls who attended the eye clinic for nonvascular entities. Polymerase chain reactions and restriction enzyme analyses were performed for genotyping 5 platelet glycoprotein polymorphisms on DNA extracted from whole blood. Frequencies of the various platelet polymorphisms. One of the 5 platelet glycoprotein polymorphisms analyzed, the B allele of the glycoprotein Ibalpha variable number of tandem repeats (VNTR), was a significant independent risk factor for NAION, with an odds ratio of 4.25 and a 95% confidence interval of 1.67 to 10.82 (P = 0.0026). All other platelet glycoprotein polymorphisms were similarly distributed in patients and controls. In addition, 9 of 16 patients who bore the VNTR B allele (56.3%) had second eye involvement, whereas among patients not harboring the VNTR B allele only 17 of 72 patients (23.6%) had second eye involvement (P = 0.009). Moreover, second eye involvement occurred earlier in patients who bore the specific polymorphism.', 'output': 'yes', '__index_level_0__': 30299}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is mannose-binding lectin deficiency associated with increased risk for polyomavirus nephropathy? Context: Polyomavirus associated nephropathy (PVAN) affects up to 10% of kidney transplant recipients and is a major risk factor for graft loss. Mannose-binding lectin (MBL) is an important recognition molecule of the innate immune system, and its deficiency has been associated with susceptibility to various infections. In transplantation, on the other hand, high MBL levels have been associated with increased tissue damage in ischemia-reperfusion models and poorer graft and patient survival in solid organ transplant patients. To investigate the relation between MBL and BK virus infection, post-transplant (post-Tx) MBL levels were determined in a cohort of de novo kidney transplant patients with and without BK viremia. 41 de novo kidney transplant patients with high (n=16, group 1) or low level BK viremia (n=25, group 2) and 64 patients without BK viremia (group 3) were included. In every patient, functional MBL levels were determined at 1-3 time points (days 30, 90 or 180) post-Tx using an MBL oligomer ELISA. MBL levels remained unchanged between days 30 and 180 post-Tx independent of BKV viremia. Frequencies of MBL deficiency (<500 ng/mL) and MBL levels were not significantly different between the 3 groups. However, group 2 patients showed a trend towards lower MBL serum levels compared to group 1 patients, notably in patients without acute rejection (p=0.076).', 'output': 'no', '__index_level_0__': 30314}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Does hyperinsulinemia acutely increase serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity? Context: Macrophage inhibitory cytokine-1 (MIC-1) plays a role in the regulation of cellular responses to stress signals and inflammation. MIC-1 has also been implicated in mediation of tumour-induced anorexia and weight loss. Increased serum concentrations of MIC-1 were found in patients with anorexia nervosa (AN), obesity and type 2 diabetes. To estimate serum MIC-1 concentration in women with AN and obese women, its regulation by hyperinsulinemia and relationship with insulin sensitivity. We examined 20 women with AN, 28 healthy normal-weight female controls and 28 obese women. Serum MIC-1 concentration was measured in the fasting state and after 2-h euglycemic hyperinsulinemic clamp. At baseline, serum MIC-1 was higher in AN in comparison with other groups (normal-weight, P = 0Â·018; obese, P = 0Â·01). Hyperinsulinemia resulted in a significant increase in serum MIC-1 concentration in the entire study population (P < 0Â·001) and in AN (P < 0Â·001), normal-weight (P = 0Â·002) and obese (P < 0Â·001) groups analysed separately. Postclamp serum MIC-1 was still higher in AN women in comparison with other groups (normal-weight, P = 0Â·012; obese, P = 0Â·023). When normal-weight and obese women were analysed together, with the exclusion of AN group, an inverse correlation between insulin sensitivity and the change in serum MIC-1 during the clamp was observed (r = -0Â·27, P = 0Â·042).', 'output': 'yes', '__index_level_0__': 30357}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Does glipizide treatment of post-transplant diabetes interfere with cyclosporine pharmacokinetics in renal allograft recipients? Context: Glipizide is an oral antidiabetic drug that has been used in the treatment of post-transplant diabetes mellitus (PTDM). However, a published case report has indicated a possible interaction of glipizide with cyclosporine (CsA) pharmacokinetics in two renal transplant (tx) patients. The aim of this open prospective study was to investigate whether glipizide interacts with CsA pharmacokinetics in renal tx patients with PTDM. Eleven renal tx patients (29-74 years of age) with PTDM who received Sandimmun Neoral as part of their immunosuppressive therapy were investigated. No patients had suffered any significant rise in serum creatinine (20%) from any cause over the last 2 wk before the study. Mean S-creatinine was 137 mumol/L (87-220). The mean CsA dose and whole blood concentration remained unchanged during the study. CsA whole blood concentrations were monitored over 12 h in all patients in random order, both on and off glipizide treatment. Blood samples were drawn immediately before the morning dose of CsA was given (trough) and 0.5, 1, 1.5, 2, 3, 4, 6 and 12 h after administration. Whole blood trough CsA concentration was not altered by glipizide treatment, 256 +/- 76 micrograms/L off and 242 +/- 73 micrograms/L (mean +/- SD) with glipizide coadministration. The area under the curve (AUC) and terminal half-life of CsA remained unchanged with glipizide treatment: 6391 +/- 1483 micrograms/L per h and 7.3 +/- 1.5 h without; and 6279 +/- 1601 micrograms/L per h and 7.1 +/- 1.8 h with glipizide, respectively. No change in the CsA peak concentration (Cmax) was observed: 1507 +/- 406 micrograms/L without and 1469 +/- 538 micrograms/L with glipizide coadministration.', 'output': 'no', '__index_level_0__': 30301}\n",
      "Task: summarization, Sampled: 50\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'the circadian variation enables the organism , system , and individual organs to maximize efficiency by ensuring optimal performance with minimal energy expenditure . \\n the diurnal variation in blood pressure rhythm has been demonstrated in man [ 13 ] and various mammalian species [ 46 ] . \\n some variations in the circadian blood pressure patterns have been attributed to endocrine influences [ 7 , 8 ] while others are thought to be of neural origin . \\n blood pressure and heart rate are thought to vary in different ways , with diurnal changes in weather , time of day , and temperature . \\n circadian rhythm involves changes in autonomic function controlled by the hypothalamus and influenced by the higher brain centers . \\n vinik and erbas   have stressed the importance of recognizing and treating autonomic neuropathy in diabetes , but early detection of autonomic neuropathy is difficult with current assessment techniques . \\n the search for more sensitive , less invasive , and less stressful markers of autonomic and cardiovascular dysfunction is still imperative . \\n have reported that the heart possesses an internal circadian clock , which is associated with gene expression , metabolism , and contractile performance . \\n they reported loss of synchronization in the phases of these circadian rhythms in streptozotocin - induced diabetes in rats . \\n loss of circadian rhythm of blood pressure following acute stroke has been reported in human patients [ 1214 ] . \\n diabetes mellitus is known to produce autonomic neuropathy , which results in functional and anatomical changes in the autonomic and cardiovascular system . \\n clinical studies have used beat - to - beat variation of heart rate during deep breathing and during the valsalva maneuver to show the altered parasympathetic nervous control of the heart in diabetes [ 16 , 17 ] . \\n other experimental studies have been carried out in streptozotocin- or alloxan - treated rats [ 11 , 18 ] . \\n the autonomic nervous system plays an important role in the regulation of cardiovascular function in health and disease . \\n however the effect of the development of diabetes and diabetic neuropathy on regulation of cardiovascular function and the circadian variability of blood pressure and heart rate has not been convincingly elucidated . \\n the development of an animal model of spontaneous autoimmune diabetes mellitus , the bbdp rat , provides a good opportunity for the study of the phenomenological changes in autonomic and cardiovascular function and the circadian variations in these parameters during the progression of type 1 diabetes mellitus . \\n this study was designed to investigate the circadian variations in blood pressure , heart rate , and blood pressure and heart rate cross - correlation ( xcorr ) in bbdp rats . \\n we posit that the circadian rhythm of blood pressure , heart rate , and heart rate - blood pressure cross - correlation in diabetic rats will differ from those of the control ( i.e. , diabetes - resistant ) rats . \\n male , genetically diabetes - prone ( bbdp ) ( n = 8) and diabetes - resistant ( bbdr ) ( n = 8) rats obtained from the biomedical models inc . \\n the experiments were performed in accordance with the national institutes of health guidelines for care and use of experimental animals   and were approved by the institutional animal care and use committee of the university of kentucky college of medicine . \\n these bbdp rats spontaneously develop an autoimmune , abrupt onset type 1 diabetes mellitus between 50120 days of age . \\n they were housed in an isolated room where the temperature was controlled at 72 degrees fahrenheit ( 22c ) , 56% humidity , and a 12/12-hour light / dark cycle . \\n the rats were fed on standard rat chow ( harlan teklad 2018 , madison , wi , usa ) and had access to water ad libitum . \\n the diabetic animals were weighed each morning , and blood glucose was measured . briefly a drop of blood from the saphenous vein was placed on the reagent strip of the one - touch ultra glucometer ( lifescan inc . , \\n the rats were anaesthetized with sodium pentobarbital ( 65  mg / kg , ip ) . the abdominal aorta was accessed via a laparotomy . \\n the sensory element of a data sciences international ( dsi ) probe ( model ta11pa - c40 ) was placed into the aorta via a puncture such that the tip pointed towards the heart . \\n the catheter containing the sensitive element of the probe was secured in place with surgical glue . \\n the body of the probe that contains the sensor , transmitter , and battery was secured to the interior abdominal wall with sutures . \\n the body weight and the blood glucose level were monitored each morning at about 9  am . the day \\n the animal first showed a morning blood glucose level above 250  mg / dl was taken as onset of diabetes mellitus and designated \\n the diabetic age was calculated from this point , which occurred at about 65 days of age . \\n this involved giving protamine - zinc insulin ( pzi ) 0.9  u/100  g / day , subcutaneously . \\n the dose was increased or reduced by 0.2 units per day , depending on weight gain or loss and plasma glucose level . \\n blood pressure was monitored continuously throughout the period or in some cases continuously for two - week intervals each month . \\n the latter arrangement or rotation helps increase the number of animals monitored and also prolongs battery life of the telemeter , as the telemetry unit is switched off . \\n the received signal was fed into a dsi data exchange matrix to which was connected an ambient pressure reference ( apr 1 ) . \\n the output from the matrix was fed , via a dataquest pci card , into the pentium iv computer - based workstation running a dataquest a.r.t system software program . the output from this computer \\n the analog output of the dem was passed through a bnc-2110 a - d converter ( national instruments ) into an analysis and output computer for further processing or display . \\n the data stream was analyzed using an in - house developed computer program ( viisoftware , lexington ) running on a pentium iv based computer . \\n heart rate ( hr ) was computed from the pulsatile bp signal . for data analysis the 24-hour day was divided into six 4-hour periods starting from 12  :  00 midnight ( p0 , p1 , p2 , p3 , p4 , and p5 ) . the blood pressure and heart rate were plotted to reveal any diurnal variations and cyclic variations . \\n two - factor between group analysis of variance ( anova ) was applied to the strains ( bbdp and bbdr ) . \\n one - way anova was used for individual changes and appropriate t - tests applied . \\n table 1 shows the parameters of the spontaneously diabetic rats ( bbdp ) at the onset of diabetes and the age - matched diabetes - resistant control rats ( bbdr ) . \\n the diabetes - prone rats had a slightly , but significantly , lower body weight than the control rats . \\n we report elsewhere   that , aside from the consistent between - group difference in absolute weight , both groups exhibited similar growth patterns during the study period . \\n likewise , we reported   that baseline mean arterial pressure ( map ) did not differ between groups and that hr was minimally , but significantly , lower in the diabetic animals versus the controls for the first 6 months after the bbdp became diabetic . \\n one diabetic rat died about day 120 of diabetic duration and another at day 244 . \\n figure 1 shows ten days of mean arterial pressure ( map ) , hr , and light / dark cycles for a diabetes - resistant animal . \\n the circadian variations in blood pressure and heart rate are demonstrably out of phase with the light / dark rhythm ( i.e. , lowest map and hr during light on ) , as would be expected for an animal that is most active during the dark . \\n panels a , b , and c of figure 2 graph map recorded for the time periods p0 ( 12 midnight4  am ) , p1 ( 4  am8  am ) , p2 ( 8  am12 noon ) , p3 ( 124  pm ) , p4 ( 4  pm8  pm ) , and p5 ( 8  pm12 midnight ) in the bbdp rats at the indicated days following their becoming diabetic . \\n each point is an across - rats average , in turn derived from a beat - by - beat average over the four - hour recordings for each time period for each subject . \\n the results show that prior to conversion ( top - left panel ) to the diabetic state ( i.e. , control , dark blue ) blood pressure was high at p0 , was lower at p1 , and rose to a peak at p2 and then fell again at p3 . \\n a similar circadian pattern was recorded for the onset of diabetes at day 0 ( panel a , maroon ) and again at day 21 ( yellow ) . by day 60 ( light blue ) \\n the peak diurnal blood pressure was shifted to period p3 ( 124  pm ) while the night time peak increased ( p5 ; 97.4  5.2  mmhg ) . \\n the circadian bp rhythms for diabetic duration 35 months are shown in figure 2(b ) ( top - right panel ) . \\n the diurnal peak of bp remained at p3 at 90 days ( maroon ) and 120 days ( yellow ) while the nighttime peak was still at p5 . at 150 days ( light blue ) peak diurnal \\n bp was at p2 ; however bp at p4 fell below the early morning dip at p1 . \\n the pattern of circadian changes in bp appeared to normalize later in diabetes , but the amplitudes of the changes are greatly reduced especially in the p3 to p4 period ( figure 2(c ) ) . \\n the diabetes - resistant rats bbdr showed no appreciable shifts in the diurnal peak period over the study period . \\n circadian changes in heart rate ( figure 3 ) followed a pattern similar to that of mean arterial pressure . prior to conversion and at day 0 heart rate was high at p0 followed by a dip at p1 and increasing to a peak at p2 ( figure 3(a ) , top - left ) . \\n however from day 21 to day 90 the peak shifted to midafternoon at p3 . beyond day 150 \\n there was a return to normal pattern with a dip at p1 and peak at p2 , another dip at p3 , and gradual rise to p4 and p5 in the night ( figures 3(b ) and 3(c ) ) . \\n the cross - correlation coefficient of heart rate and blood pressure   in the diabetic animals in the six time periods looks  parabolic  with p0 and p5 having the highest values ( p0 : 0.65  0.031 ; p5 : 0.68  0.019 ) , while the periods p3 and p4 had the lowest values ( 0.49  0.036 , 0.50  0.04 , resp . ) in the control recording ( figure 4(a ) ) . \\n the cross - correlation coefficient was elevated relative to control at p1 and p2 at the onset of diabetes ( i.e. , day 0 , maroon ) . by days 21 and 60 \\n there was a midday peak at p2 with dips at p1 and p3 showing a change in pattern . \\n the late diurnal coefficient showed little or no change from p3 to p5 at diabetic age 120150 days ( figure 4(b ) ) . with an increase in diabetic age the amplitude of the variation in cross - correlation coefficient across the 24-hour day \\n was reduced by day 244 , but overall values remained high . however , by the 9th month the cross - correlation coefficient fell significantly with a peak at p2 and lowest dip at p5 ( 0.39  0.06 ) ( figure 4(c ) ) suggesting impairment or degeneration of integrative functions . \\n in contrast the nondiabetic control rats maintained a higher cross - correlation coefficient and did not manifest a dip at p5 ( bbdr : 0.65  0.03 , p < .05 versus bbdp , 0.39  0.06 ) .  \\n figure 5 shows the effect of diabetic age on the circadian cross - correlation coefficient in the diabetic rats . \\n note that , in the pre - conversion period ( i.e. , n14 to n1 ) , there was considerable daily fluctuation in the cross - correlation coefficient ( 0.46 to 0.69 ) . \\n after conversion the range of the daily fluctuation narrowed , and by day 21 all the periods had converged ( 0.6 to 0.67 ) ; thereafter ( day 60 to day166 ) the cross - correlation coefficient again showed a wide circadian fluctuation which was sometimes higher than the pre - conversion values . around day 244 \\n this reduction was steady and continued as the cross - correlation coefficient started to decline by day 273 . \\n the graph shows that apart from the daily rhythm , there is also a long - term periodic cycle of about one - month duration exhibited by this parameter . \\n this fairly regular pattern was diminished later ( from day 180 ) in the diabetes . \\n the lead / lag times of the cross - correlation between hr and bp in the circadian period of the diabetic rats are shown in figure 6 . \\n the negative values of the lead / lag plot indicate that heart rate changes led blood pressure changes by the indicated value ( in sec . ) . in the pre conversion period \\n the values for the night and early morning periods ( p0 , p1 , p4 , and p5 ) were generally higher ( 2.0 to 2.3 sec ) while those for midday ( p2 and p3 ) were lower ( 1.6 to 2.0 sec ) . \\n however about day 21 in the postconversion period there was a change in the trend with the continued reduction of the nighttime lead values , especially between day 21 and day 90 . \\n there was gradual reduction in the lead / lag time for the various periods as the diabetes progressed ; however , by day 244 the diurnal circadian variation was significant with p0 ( nighttime ) having the highest lead ( 2.0  0.06 sec ) while p3 ( afternoon ) had the lowest ( 1.45  0.07 sec ) . \\n when the changes were aggregated ( figures 7(a ) and 7(b ) ) the average cross - correlation coefficients of the peak ( figure 7(a ) ) and nadir ( figure 7(b ) ) showed less fluctuation in the control diabetic - resistant rats suggesting that the between group differences are not primarily due to maturation . \\n results from this study in an animal model of spontaneous type 1 diabetes mellitus are associated with changes in resting circadian cardiovascular and autonomic functions . \\n it is also established that central suprachiasmatic nucleus and related structures act as circadian pacemakers for the whole body [ 24 , 25 ] . \\n the interplay of the central and peripheral oscillators enables the organism to adjust the activities of its organs to maximize efficiency while functioning optimally in a changing environment . \\n our results show that at the onset of diabetes up to the 3rd diabetic week blood pressure had two peaks at midnight / morning , and midafternoon , interlaced with a dip in the morning and followed by another dip late afternoon . \\n in this longitudinal study a phase shift was seen by the 2nd diabetic month in which the diurnal blood pressure peak shifted from midafternoon to late afternoon ( p3 ) . \\n this new pattern was sustained to the third and fourth months of the duration of diabetes . \\n the prediabetic pattern of blood pressure changes was displayed beyond the fifth month , but the amplitude of the rhythm was reduced . \\n the cross - correlation coefficient of heart rate and blood pressure showed wide circadian variation in the pre - conversion period , and the amplitude of the rhythm reduced in the postconversion period and showed little or no fluctuation in the late afternoon - night section during the third to the fifth diabetic month . a sharp fall in the cross - correlation coefficient followed in the 9 - 10th month with reduction of the diurnal range . \\n our results suggest that there is also a seasonal rhythm of oscillation in cross - correlation coefficient with a periodicity of about sixty days . \\n the lead time of the peak lead / lag plot of the cross - correlation coefficient was negative throughout the study showing that heart rate change was leading blood pressure change . \\n this value diminished with diabetic age but did not overturn , suggesting that sympathetic efferent control of the cardiovascular system was maintained , but with reduction in effectiveness . \\n the diurnal rhythm showed that the heart rate lead over blood pressure was longer in the morning period ( p1 ) before and at onset of diabetes . \\n the combination of the spontaneously diabetic rat model and telemetry has proven advantageous for this long - term longitudinal study of the circadian cardiovascular and autonomic function in diabetes . \\n our findings are consonant with earlier reports of time - dependent alterations in heart rate , circadian variation , pulse pressure , and cardiac autonomic control in streptozotocin- ( stz- ) treated rats [ 18 , 26 , 27 ] . \\n young et al .   have also reported alteration of internal circadian clock in the heart of stz - treated rats . \\n the former were acute studies or intermittent - duration studies lasting one day , 8 weeks , and ten weeks , respectively , and some used indwelling arterial cannula for blood pressure measurement . \\n to the best of our knowledge the present study is unique because we not only measured continuous prediabetic data , but we also recorded during the diabetic conversion period and , thereafter , continuous , long - term cardiovascular function . \\n our observations reveal that there is yet another rhythmic long - term variation of cardiovascular function . \\n this rhythm has a periodicity of about sixty days which is not obvious in diabetes - resistant rats . \\n the mechanisms underlying the reported changes in cardiovascular function were thought to be in the heart and/or neuroendocrine control . \\n it has been recognized that stz - induced alterations of the circadian clock of the heart may be independent of diabetes development . \\n our results do not show a dramatic change in heart rate at onset of diabetes . \\n this is in contrast with the severe bradycardia of about 20%   and 30%   in earlier reports that used stz . \\n other reports on isolated cardiac preparations have associated stz diabetes with depression of basal spontaneous pacemaker rate [ 2931 ] , which was not affected by nadolol or atropine [ 31 , 32 ] . \\n it was thought that changes in electrophysiological properties of the sinoatrial ( sa ) node of the heart , such as maximum diastolic potential , threshold , or slope of diastolic depolarization , were responsible . \\n this may be due to central effect(s ) on cardiovascular system via the autonomic nervous system . \\n we have applied computational cross - correlation coefficient analysis of the changes in heart rate and blood pressure to the circadian rhythm and the long - term variability of heart rate and blood pressure in these animals . \\n this method has been shown to be advantageous for investigating dynamic arterial blood pressure and heart rate control [ 21 , 33 ] . \\n this method revealed different changes in circadian rhythms at different times in the development of diabetes . in the control period the circadian rhythm consisted of a unipodal curve with a peak in the night and a dip in the midday . \\n immediately at conversion to diabetes the circadian rhythm showed a sustained peak of the cross - correlation coefficient into the mornings . \\n however by the second month the relationship changed to a bipodal curve with peaks in the night and midday and dips in the morning and afternoon . \\n the cross - correlation coefficient remained positive indicating   that sympathetic control was maintained , though with fluctuations . \\n thus it can be surmised that in this period permanent damage to autonomic regulatory mechanisms may not have occurred , but some destabilization of the resting tone may be in place . in the ninth month we observed a significant reduction in cross - correlation coefficient and a phase shift in the peaks and dips with the nighttime having the lowest dip , and this did not occur in the diabetes - resistant rats . \\n this may mark the beginning of irreversible impairment of autonomic and cardiovascular function . in classic blood pressure driven changes as in baroreflex tests , haemorrhage and postural change , \\n bp change is followed reflexly by a compensatory change in hr yielding a negative cross - correlation with bp leading hr . while this is true for volume expansion , compartment reduction via vasoconstriction or vasodilation , this appears not to hold true for euvolemic and nonbaroreflex adjustments . in conclusion , \\n our observations show that in the development of diabetes the circadian cardiovascular rhythms show slight alterations , though these changes only became significant at the late stage of the disease . \\n this is consistent with impairment of integration and/or functional autonomic capacity in prolonged diabetes mellitus .', 'output': 'circadian changes in cardiovascular function during the progression of diabetes mellitus in the diabetes prone rat ( bbdp ) ( n = 8) were studied . \\n age - matched diabetes - resistant rats ( bbdr ) served as controls . \\n bp was recorded via telemetry in contiguous 4  hr time periods over 24 hours starting with 12 midnight to 4  am as period zero ( p0 ) . \\n prior to onset of diabetes bp was high at p0 , peaked at p2 , and then fell again at p3 ; bp and heart rate ( hr ) then increased gradually at p4 and leveled off at p5 , thereby exhibiting a bipodal rhythm . \\n these patterns changed during long - term diabetes . \\n the cross - correlation coefficient of bp and hr was not significantly different across groups at onset , but it fell significantly at 9 months of duration of diabetes ( bbdp : 0.39  0.06 ; bbdr : 0.65  0.03 ; p < .05 ) . \\n these results show that changes in circadian cardiovascular rhythms in diabetes mellitus became significant at the late stage of the disease .', '__index_level_0__': 30519}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'ramadan is the 9 month of the muslim calendar when the holy quran was sent down from heaven . fasting ( sawm ) during ramadan , one of the five pillars of islam , is obligatory for all healthy adult and adolescent muslims from the age of 12 years . \\n depending on the geographical location and season , the duration of the daily fast may range from a few to 20 h. muslims who fast during ramadan must abstain from eating , drinking , taking oral medications , and smoking from early dawn ( sohur ) until sunset ( iftar ) . \\n the main meal , iftar is taken at sunset and usually heavy meal with extra sweet foods and deeply fried food . \\n children , elderly people , travelers , pregnant or nursing women and sick individuals are exempted from fasting . \\n although exempted , many muslims , both adults and children refuse to take this concession as they feel psychologically and spiritually inclined to fast along with other muslims . \\n fasting during the day influences the control of diabetes because of changes in meal times , the type of food eaten and daily life - style . therefore , there is high risk of developing acute complications like hypoglycemia or ketoacidosis during fasting . \\n on the other hand , the excessive consumption of sweet and fried foods especially with the iftar meal may pre - dispose to hyperglycemia . \\n many patients with diabetes insist on fasting during ramadan , creating a challenge for themselves and their health care providers despite knowing all the risks . \\n there are limited studies on ramadan and most of studies have been done in adults with type 2 diabetes . \\n there is one observational study done in children and adolescents using conventional regimen with twice - a - day soluble insulin ( actrapid ) with isophane ( insulatard ) . \\n the american diabetic association workgroup suggested that care of the fasting diabetic must be highly individualized . medical assessment and education \\n there should be frequent monitoring of blood glucose , especially for those who are on insulin . a healthy balanced diet should be maintained . \\n complex carbohydrates are recommended at the predawn meal , which should be taken as late as possible and simple carbohydrates at the sunset meal . \\n fluid intake should be increased in the non - fasting hours . a normal level of activity should be maintained , avoiding excessive activities in the hours before the sunset meal . \\n the fast should be broken if glucose level is low ( < 4 mmol / l ) or patient experiences signs / symptoms of hypoglycemia and if blood glucose level is > 16.7 mmol / l . \\n some experienced physicians are of the opinion that fasting during ramadan is safe for type 1 diabetes mellitus ( t1 dm ) patients including adolescents and older children with good glycemic control who do self - monitoring and are under close professional supervision . in bangladesh , \\n more than 90.0% of the population are muslims . many children and adolescents with diabetes insist to fast , but there is no study on children and adolescents who fast during ramadan in bangladesh . \\n this study was conducted to see the safety and changes in hemoglobin a1c weight , episodes of hypoglycemia in patients who did fasting during ramadan . \\n a prospective observational study was designed for diabetic children and adolescents who wish to fast during ramadan at changing diabetes in children program ( cdic ) clinic in birdem , dhaka , bangladesh . \\n children aged 11 - 18 years , willing to do frequent blood glucose monitoring at least 2 - 3 times / day were included . \\n we excluded children with sustained poor glycemic control , those with history of diabetic ketoacidosis ( dka ) within 3 months prior to ramadan and those unwilling to undertake blood glucose monitoring . \\n all patients on twice - a - day regimen were advised to take their usual morning dose before their sunset meal ( iftar ) and to take the evening dose at the time of sohur . \\n patients were asked to monitor blood glucose at pre - iftar , pre - sohur and at any time during the day when they feel symptoms of hypoglycemia . \\n patients were instructed to break their fast if blood sugar level was < 4 mmol / l or if they experience symptoms of hypoglycemia and if blood glucose level > 16.7 mmol / l . \\n all patients were instructed to call health - care providers for dose adjustment whenever necessary or if there was any episode of hypoglycemia . \\n patients were asked to record the information of blood glucose measurements , ability to maintain fast on their home monitoring blood glucose ( hmbg ) book . \\n patients with their caregivers were given intensive education and instructions were provided by diabetic educators , dieticians and physicians on insulin adjustment , home glucose monitoring and dietary adjustments prior to ramadan . \\n the p < 0.05 was considered to be the cut - off value of significance . \\n 16 were male and 17 were female . majority ( 60.6% ) of the patients could complete their fasting during the ramadan . \\n patients were divided into two groups , those who completed fasting were considered as group - i ( 20 children ) , whereas patients who broke the fast were in group - ii ( 13 children ) . \\n mean ( sd ) age was 13.5  2.0 in fasting group and was 13.4  2.0 in the other group [ table 1 ] . \\n female ( 65.0% ) participants were higher than male ( 35.0% ) in group - i whereas male 69.2% were higher than female ( 30.8% ) in group - ii . \\n mean duration of diabetes was 21.7  27.3 months in group - i compared with 15.1  15.3 months in group - ii [ table 1 ] . comparing the mean age , duration of diabetes and hypoglycemia in two groups two patients missed school for one day , one from group - i and another one from group - ii [ table 1 ] . \\n two ( 10.0% ) patients in group - i developed mild symptoms of hypoglycemia , one before iftar and another patient after iftar at night . \\n three ( 23.1% ) patients from group - ii developed mild hypoglycemia and broke the fast [ table 1 ] . \\n however , there was no incidence of dka or associated ketones in both groups [ table 1 ] . sixty six percent ( 66.0% ) patients in group - i and seventy five percent ( 75.0% ) in group - ii did hmbg regularly as per instruction . \\n mean glucose level before iftar was higher in group - i compared that in group - ii [ table 2 ] . in group - ii \\n mean blood glucose before sohur was higher compared with that in group - i [ table 2 ] . \\n blood glucose , hba1c , weight and insulin dose before and after ramadan in two groups the mean hemoglobin a1c for the fasting group was 8.5% 2.94 before ramadan and 8.1  2.40 , 3 months after ramadan and was 8.9% 2.17 and 9.4% 2.41 in the other group respectively [ table 2 ] . at the beginning of ramadan , the weight of patients in group - ii was higher ( mean of 55.38 kg ( 18.8 ) than that of the fasting group , ( mean of 51.45 kg ( 9.95 ) [ table 2 ] . \\n there was mild weight reduction in both groups after the ramadan [ table 2 ] . \\n insulin dose was increased in group - i whereas insulin dose was reduced in group - ii during ramadan [ table 2 ] . \\n in the past , fasting during ramadan has not been recommended for type 1 diabetics because of the risk of hyper or hypoglycemia . \\n however , current evidence has proved that with proper education , appropriate adjustment of the drug regimen , diet control and daily activity , it is safe for adult diabetics with type 1 and type 2 to fast during ramadan . \\n regimens using short acting insulin before meals with a long - acting insulin in the evening have been safely used in adults . \\n our study in t1 dm showed that most of children with conventional insulin regimen could complete the fast . \\n the management of children with diabetes who choose to fast during ramadan is a challenge for the pediatrician as the majority of guidelines and data on safety and metabolic impact of fasting are based on practice and studies on the adult population . \\n majority of our patients completed the full month of fasting , only two had mild hypoglycemia and none had dka . \\n therefore , our study showed that it is safe for diabetic children over the age of 11 years to fast , provided that a well - structured program of education for both children and their families is completed prior to ramadan and that they receive close follow - up during the month of ramadan . \\n data on the effects and safety of ramadan fasting in healthy and diabetic adolescents are sparse . \\n an earlier study done in riyadh on children with similar age group reported three children with biochemical hypoglycemia within the 1 week of fasting . in our study , \\n 10.0% patients developed hypoglycemia in fasting group compared with 33.3% of patients who broke the fast . in one study , \\n eight patients ( 61.5% ) on basal  bolus regimen and 4 ( 44.0% ) on conventional insulin broke their fast on at least one occasion because of hypoglycemia . \\n the reasons for lower hypoglycemia episodes in our patients may be the parental supervision , intensive education , insulin adjustment , monitoring over phone and regular follow - up in cdic clinic . \\n it is also possible that adequate food intake and higher hba1c in our patients provided them with protection against hypoglycemia . in our population , there was weight reduction but there was increased in weight in majority of patients in one study , which could be attributed to adequate amount of balanced diet taken by our patients as per the dietary advice given by our dietitian . \\n our study population was very small in number but still demonstrates that children over the age of 11 years who had proper education , insulin dose adjustment and were under close follow - up had less number of complications and were able to successfully complete fasting during the month of ramadan . \\n children older than 11 years of age with t1 dm with conventional twice - a - day regimen can fast safely during ramadan provided they have proper education and intensive follow - up during ramadan . however , further studies with large population are recommended to expand our knowledge in management of childhood diabetes during ramadan .', 'output': 'background : fasting ( sawm ) during ramadan , one of the five pillars of islam is obligatory for all healthy adult and adolescent muslims from the age of 12 years . \\n some children with diabetes , despite their exemption insist on fasting in ramadan . \\n we evaluated the safety of fasting among children with type 1 diabetes.materials and mathods : a prospective observational study was designed for diabetic children and adolescents who wish to fast during ramadan 2012 . \\n patients with their caregivers were given intensive education and instructions were provided by diabetic educators , dieticians and physicians on insulin adjustment , home blood glucose monitoring and dietary adjustments prior to ramadan.results:a total of 33 children and adolescents were included in this study . \\n of these , 16 were male and 17 were female \\n . majority ( 60.6% ) of the patients could complete their fasting during the ramadan . \\n patients were divided into two groups , those who completed fasting were considered as group - i , whereas patients who broke the fast were in group - ll . \\n blood glucose , hemoglobin a1c weight , and insulin dose before and after ramadan in two groups showed no significant difference.conclusion:children older than 11 years of age with type 1 diabetes mellitus with conventional twice - a - day regimen can fast safely during ramadan provided they have proper education and intensive follow - up during ramadan .', '__index_level_0__': 30442}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'in the last decades health professionals have been often organized into many specialties \\n and subspecialties directed to several body organs and systems . \\n the human organism is a \\n unity that is composed by an infinite number of biologic processes so strongly linked \\n that abnormalities in any part of the body and/or its processes may have deep effects in \\n many other body areas , exemplified in this review by two highly prevalent diseases : pd \\n and dm . \\n an imbalance \\n between a localized infection and an exaggerated host inflammatory response plays a \\n pivotal role in determining gingival tissue damage . \\n recent evidence suggests that the \\n effect of pd might not be limited just to the oral cavity but it might have systemic \\n consequences . \\n although , the mechanisms behind this association remain unclear , pd might \\n represent one distant source of low - grade systemic inflammation . \\n this association could \\n explain the increased risk of impaired metabolic control in diabetes - related \\n complications and the adverse effects of dm on periodontal health . \\n there is strong evidence that the \\n prevalence , severity and progression of pd are significantly higher in people with \\n dm . in this review \\n we describe the common processes involved in pd and dm and briefly review \\n the evidence produced to support an association between pd , dm and diabetes - related \\n complications . \\n pd is a chronic bacterial infection that affects both the gingiva and the bone that \\n supports the teeth and is caused by anaerobic gram - negative microorganisms that are \\n present in the bacterial plaque that adheres to the teeth . \\n pd is a very prevalent condition . in the united states , over half the population aged \\n 18 years or more have pd in its early stages , increasing to up to 75% after the age \\n of 35 years ; its mild to moderate forms are present in 30% to 50% , and \\n pd has even higher prevalence in \\n minorities , in poor and developing countries and a considerable global \\n variation . \\n the presence of anaerobic gram - negative bacteria causes a local inflammatory response \\n that becomes chronic and progressive ; this inflammation of the gingiva causes \\n alveolar bone destruction and loss of the tissue attachment to the teeth , caused by \\n components of microbial plaque that have the capacity to induce an initial infiltrate \\n of inflammatory cells , such as lymphocytes , macrophages , and polymorphonuclear \\n leukocytes ( pmns ) . \\n some microbial components , especially lipopolysaccharide ( lps ) , activate macrophages \\n that synthesize and secrete a great variety and amount of pro - inflammatory molecules , \\n such as the cytokines interleukin-1 ( il-1 ) and tumor necrosis factor- ( tnf- ) ; \\n prostaglandins , especially prostaglandin e2 ( pge2 ) ; and some other enzymes . \\n bacterial toxins can also activate t lymphocytes to produce il-1 and lymphotoxin \\n ( lt ) , a molecule with properties that are similar to those of tnf-. these cytokines \\n show potent pro - inflammatory and catabolic activities , and have important roles in \\n periodontal tissue destruction caused by collagenolytic enzymes such as \\n metalloproteinases ( mmps ) . \\n these \\n collagenolytic enzymes are activated by reactive oxygen species and elevate the \\n levels of interstitial collagenase in inflamed gingival tissue . \\n the attachment loss deepens the sulcus , creating a periodontal pocket that contains \\n thousands of millions of bacterial cells . \\n this stage is the transition between \\n gingivitis and periodontitis , the most common pds . \\n when bacterial biofilms on the teeth are not disrupted on a regular basis , the \\n emergences of gram - negative anaerobic bacterial species activate several host \\n processes that will interfere in the extent and severity of the disease . \\n recently , many advances have occurred in the knowledge of the nature of the \\n infectious agents involved in pd . \\n approximately 500 different bacterial entities and \\n various human viruses have already been associated with the formation of dental \\n microbial plaque . \\n the most frequently recognized periodontal pathogens belong to three microaerophilic \\n species ( actinobacillus actinomycetemcomitans , campylobacter rectus , \\n and eikenella corrodens ) and seven anaerobic species \\n ( porphyromonas gingivalis , bacteroides forsythus , treponema denticola , \\n prevotella intermedia , fusobacterium nucleatum , eubacterium , and \\n spirochetes ) . \\n various herpes viruses , such as the human cytomegalovirus ( hcmv ) and epstein - barr \\n virus ( ebv-1 ) , have recently also emerged as pathogens in cases of destructive \\n pd . \\n many conditions can predispose and/or facilitate the occurrence of pd such as \\n smoking , genetic influences , estrogen \\n deficiency , estrogen \\n excess , \\n dyslipidemia and obesity . \\n this epidemic is also associated with an increased occurrence \\n of obesity - related diseases like hypertension , cardiovascular disease , metabolic \\n syndrome and dm that are also linked to pd . \\n dm encompasses a group of genetically and clinically heterogeneous metabolic \\n disorders characterized by hyperglycemia that results from a defective insulin \\n secretion and/or activity . \\n dm is classified according to its etiology as type 1 ( t1d ) , type 2 ( t2d ) , gestational \\n diabetes ( gdm ) and other specific types . \\n t1d results from the destruction of \\n beta - cells within the islets of langerhans of the pancreas , which results in a \\n complete insulin deficiency ; it can be immune - mediated or have an idiopathic \\n etiology . \\n t2d ranges from an insulin resistance which progresses into an insulin \\n deficiency due to a secondary failure in the pancreatic beta - cells . \\n gdm is defined as \\n any degree of glucose intolerance with onset or first recognition during pregnancy . \\n lastly , the category \" other specific types \" comprehends a group of several types of \\n dm with different etiologies . \\n developed countries have a higher prevalence of dm than developing countries and more \\n women than men are affected with dm . \\n the \\n prevalence of dm in adults all over the world was estimated to be around 4.0% and it \\n was expected to rise to 5.4% by the year 2025 . numerically it means a rise from 135 \\n million in 1995 to 300 million in the year 2025 . \\n an increase of 42% ( from 51 to 72 million ) is expected \\n in developed countries and an increase of 170% ( from 84 to 228 million ) in the \\n developing world . \\n therefore , it is expected that by the year 2025 , 75% of people with \\n dm will be living in developing countries where the majority of people with dm are \\n aged between 45 - 64 years old . \\n in developed countries , the majority of people with dm \\n are older than 65 years . \\n people with diabetes and with chronically poor metabolic control can experience \\n micro - vascular and macro - vascular complications leading to a significant burden for \\n the individual and for the society . \\n this burden includes direct costs of medical care \\n and indirect costs , such as loss of productivity , which result from diabetes - related \\n morbidity and premature mortality . health care expenses for people with diabetes is more than two - times higher than the \\n expenses for people without diabetes ; the direct and indirect expenditures \\n attributable to diabetes in 2007 in the usa were estimated at us$174 billion , with \\n slightly more spent on chronic complications attributable to dm than properly on dm \\n care . \\n the international \\n diabetes federation estimated that dm costs account for 5 - 10% of the total healthcare \\n budget in many countries . in brazil , \\n the per capita total , direct medical , direct nonmedical \\n and indirect costs of patients with t1d were us$ 1,741.42 , us$ 1,319.15 , us$ 61.47 \\n and us$ 360.81 , respectively . \\n the total direct non - medical costs were us$ 195,461.54 , \\n spent with transportation for the patients and caregivers . \\n total annual costs for care of outpatients with t2d \\n were us$ 2,108 per patient , out of which us$ 1,335 per \\n patient of direct costs ( 63.3% ) and us$ 773 per patient of \\n indirect costs ( 36.7% ) . \\n patients with both micro - vascular and macro - vascular \\n complications had higher costs ( us$ 3,199 per patient ) compared to \\n those with either micro - vascular ( us$ 2,062 per patient ) or \\n macro - vascular ( us$ 2,517 per patient ) complications only . \\n the \\n greatest amount of direct costs was attributed to medication ( 48.2% ) . the search conducted for \\n this review used the bbo ( bibliografia brasileira de \\n odontologia ) , medline , lilacs and pubmed for controlled trials databases , in english \\n and portuguese languages published from 1960 to october 2012 . \\n primary research \\n reports on investigations of relationships between dm / dm control , pd / periodontal \\n treatment and pd / dm / diabetes - related complications identified relevant papers and \\n meta - analyses published in this period . \\n the identified reports are displayed in figures organized \\n according to the following groups : 1- the effects of dm on pd ; 2- the effects of \\n glycemic control on pd and 3-the effects of pd on glycemic control and on \\n diabetes - related complications . \\n the studies listed in figure 1 compared \\n periodontal status in individuals with and without dm in the majority of the reports . \\n these studies were classified according to the study design , type of diabetes , sample \\n number , age range , evaluation of pd and other diabetes - related variables . \\n the \\n majority of the studies were cross - sectional ( 21/29 ) and limited in the possibility \\n of providing a causal - effect relationship . \\n effects of diabetes mellitus on periodontal disease pd= periodontal disease - dm = diabetes mellitus - t1d = diabetes mellitus type \\n 1 - t2d = diabetes mellitus type 2 - gdm = gestational diabetes mellitus the link between dm and the adverse effects on pd has been extensively \\n described . \\n we have found that 27 in 29 studies showed \\n supportive evidence of the adverse impact of dm on periodontal health . \\n there were four studies of t1d ; one study reported more extensive radiographic bone \\n loss in patients with t1d compared to the controls , lalla , et al . \\n ( 2006 ) in a case - control study found that periodontal \\n destruction can start very early in life in patients with t1d and becomes more \\n prominent as children become adolescents . in a population aged 4 to 33 years , \\n ( 1982 ) reported a \\n significantly higher prevalence of pd in t1d than in non - diabetic siblings and \\n non - diabetic unrelated controls . \\n the prevalence of pd among 11- to 18-year - old \\n teenagers with dm was 9.8% as compared to 1.7% in controls without dm . \\n an accelerated \\n periodontal destruction was found in children and teens with dm , with poor metabolic \\n control . in an adult \\n population aged 40 - 69 years \\n , 58.4% of patients with long standing t1d exhibited \\n severe pd as opposed to 7.1% of controls without dm . \\n two \\n reports were comprised of patients aged 15 years or older , and \\n twelve included only adults . \\n twelve of these fourteen \\n studies reported significantly poorer periodontal health in subjects with t2d , \\n whereas a significantly poorer greater prevalence was found in one study and no significant difference was \\n found in another study . \\n six reports consist of analyses in which subjects with t1d and t2d were analyzed \\n together without distinction of diabetes type . four studies included children and \\n adolescents and another \\n five of these six studies reported greater \\n prevalence , extent , or severity of pd in subjects with dm . \\n one report did not \\n find significant differences in pd between subjects with and without dm when an \\n adequate metabolic control was found in the former group . regarding gdm , \\n one was conducted only with women with gdm \\n that were compared to a control group between the 34 - 36 gestation weeks . \\n the results of the study suggest that gingivitis seems to be more prevalent in women \\n with gdm compared to healthy pregnant women and the plaque accumulation seems to be \\n the main cause of gingival inflammation . \\n another study found that all types of dm increase the risk of \\n pd , including gdm . \\n two other \\n studies conducted in the usa collected data from over 4,000 women with a history of \\n gdm . \\n one report included ages 15 - 44 and the other , ages 20 - 59 . both reports concluded there is a strong relationship \\n between gdm and pd . \\n pd was found in 45% of pregnant women with gdm \\n vs. 13% in the healthy pregnant women , with an adjusted odds \\n ratio of 9.11 . in non - pregnant women , 40% of women with t1d or t2d , 25% of those with \\n a history of gdm , and 14% of healthy women had pd . the odds ratio for those with t1d \\n and t2d was 2.76 . \\n ( 2006 ) found the \\n prevalence of pd to be higher in women with a history of gdm and concluded that these \\n women may be at greater risk for developing more severe pd , than women without a \\n history of gdm . \\n finally , taylor \\n ( 2001 ) and mealey ( 2006 ) in two \\n extensive literature reviews found a bidirectional interrelationship between all \\n types of dm , including gdm and pd . \\n two of these studies included subjects with t1d exclusively , seven studies subjects \\n with t2d exclusively and five a combination of subjects with either t1d , t2d , gdm and \\n others ( figure 2 ) . \\n one prospective study \\n conducted with t1d did not show any association between the degree of glycemic \\n control and pd but a positive association with local oral hygiene measures , and another study , that was \\n cross - sectional , has regarded this association . \\n five of the seven reports published regarding the \\n association between glycemic control and pd in t2d have found this \\n association and two did not . \\n we have found five studies providing \\n information on the differences in periodontal health in groups of mixed types of \\n diabetes ; three have found this association and two did not . among these fourteen studies , \\n eleven were cross - sectional that \\n imposes some limitations on the cause - effect inference ; two were prospective and one \\n was an extensive literature review . \\n otherwise , nine of these reports support the \\n evidence of greater prevalence , extent and severity of pd and also provide evidence \\n that glycemic control worsens in parallel with the worsening of pd . \\n effects of glycemic control on periodontal disease ( gdm= gestational diabetes \\n mellitus ) substantial evidence has been demonstrating dm as a risk factor for the impairment of \\n periodontal health and a growing body of evidence has been supporting pd as having an \\n adverse effect on glycemic control and on the pathophysiology of diabetes - related \\n complications . \\n the inflamed periodontal tissue may serve as a chronic source of \\n bacteria , bacterial products and many inflammatory mediators such as tnf- , il6 , and \\n il1 that have been shown to have important effects on lipid and glucose \\n metabolism and have also been reported to be \\n insulin antagonists and related to insulin resistance that is predominantly found in \\n t2d and gdm . \\n as shown in figure 3 , data interpretation is \\n often confounded by varying definitions of dm and pd and different clinical criteria \\n applied to determine the prevalence , extent , severity of pd , levels of glycemic \\n control and diabetes - related complications ; there is also marked heterogeneity in the \\n studies \\' designs , conduct , length of follow - up , types of participants , and \\n periodontal treatment protocols . \\n effects of periodontal disease on glycemic control and diabetes - related \\n complications abbreviations : rct , randomized controlled trial ; non - rct , non - randomized \\n controlled trial - treatment study ; d , days ; wk , weeks ; m , months ; y , years ; \\n hba1 c , glycated hemoglobin - pd= periodontal disease - dm = diabetes mellitus \\n - t1 d = diabetes mellitus type 1 - t2d = diabetes mellitus type 2 - \\n gdm = gestational diabetes mellitus evidence regarding the effects of pd on glycemic control comes from observational and \\n treatment studies ( figure 3 ) . \\n the treatment \\n studies are a set of reports that include ten randomized clinical trials ( rcts ) , \\n twelve non - rcts , four meta - analyses , one literature review , one longitudinal study , \\n one transversal study , one retrospective study , one prospective study and two \\n clinical cases discussions . the rcts used control groups that were either treated controls , non - treated controls \\n or controls that did not change their usual dental care . \\n among the ten rcts , eight \\n reported a beneficial effect for periodontal therapy and two did not . \\n one of the rcts , recently conducted , \\n showed significant improvement in hba1c levels but did not result in a statistically \\n significant improvement in serum levels of inflammatory markers such as hs - crp , \\n d-8-iso , mmp-2 and mmp-9 . \\n an important source of variation in the rcts is the use of antibiotics with the \\n non - surgical periodontal therapy . \\n this fact brings a lot of confusion in the \\n interpretation of the results of these trials in such a way , that to date , there is \\n no clear evidence to support a requirement for the use of antibiotics in combination \\n with non - surgical periodontal treatment in order to observe an improvement in \\n glycemic control associated with periodontal therapy . among the group of twenty - three periodontal treatment studies that were not rcts , \\n like the rcts , there was marked variation in the \\n use of adjunctive antibiotics , with six of the eight studies that used systemic \\n antibiotics reporting a beneficial effect on glycemic control . \\n additional evidence to support the effect of severe periodontitis on increased risk \\n for poorer glycemic control comes from two longitudinal observational studies . \\n a \\n longitudinal epidemiological study of the pima indians in arizona , usa , which present \\n the world \\'s highest reported prevalence of dm , found that subjects with t2d in good to moderate control and \\n with severe periodontitis at baseline were approximately six times more likely to \\n have poor glycemic control at a 2-year follow - up than those without severe \\n periodontitis at baseline . \\n ( 1998 ) in another \\n observational study of 25 adults with t2d , aged 58 - 77 years , also reported an \\n association between advanced periodontal disease and impaired metabolic \\n control . \\n recently , some important trials have recognized that poor glycemic control is a major \\n determinant for the development of the chronic complications of dm . \\n the diabetes \\n control and complications trial , the epidemiology of diabetes interventions and \\n complications ( edic ) trial , the long - term follow - up study of the dcct , both conducted \\n with t1d and the united kingdom prospective diabetes study ( ukpds ) conducted with \\n t2d , demonstrated that attaining and maintaining good glycemic control could reduce \\n the risk for and/or postpone the progression of micro - vascular complications in \\n patients with t1d and t2d . \\n initially , the ukpds observed a statistically non significant 16% reduction ( p=0.052 ) \\n in the risk of combined fatal or nonfatal myocardial infarction and sudden death . \\n recently , it was observed that a long - standing good metabolic control can bring \\n significant long - term consequences including the reduction in the risks of fatal or \\n nonfatal myocardial infarction and sudden death . \\n the epidemiological analysis from \\n the ukpds showed a continuous association between the risk of cardiovascular \\n complications and glycemic control ; every percentage point decrease in hba1c , was \\n associated with a 25% reduction in diabetes - related deaths , 7% reduction in all - cause \\n mortality , and a 18% reduction in combined fatal and nonfatal myocardial \\n infarction . \\n some observational studies regarding the association between pd and the risk for dm \\n complications have given strong evidence for this association . in a study conducted \\n in sweden , with 39 case - control pairs of individuals with t1d and t2d for a median \\n follow - up time of six years , thorstensson , et al . \\n ( 1996 ) observed a significantly higher prevalence \\n of proteinuria and cardiovascular complications such as stroke , transient ischemic \\n attacks , angina , myocardial infarction and intermittent claudication in the case \\n group than in controls . \\n these findings suggest that an association between renal \\n disease , cardiovascular disease and its complications and severe periodontitis seems \\n to exist . \\n ( 2005 ) , studied \\n the contribution of pd to the mortality associated with t2d in the gila river indian \\n community in arizona , usa , on behalf of the national institute of diabetes and \\n digestive and kidney diseases , addressing nephropathy and cardiovascular disease . \\n this was a prospective longitudinal study with a cohort of 628 individuals , aged \\n approximately 35 years old , for a median follow - up of eleven years ( range 0.3 to 16 ) . \\n during the study period 204 subjects died . \\n individuals with severe pd had 3.2 times \\n greater risk for cardio - renal mortality ( i.e. , ischemic heart disease and diabetic \\n nephropathy combined ) compared with the reference group ( no , mild , or moderate pd \\n combined ) , after adjustment for several major risk factors of cardio - renal mortality \\n such as age , sex , diabetes duration , hba1c , body mass index ( bmi ) , hypertension , \\n blood glucose , cholesterol , electrocardiographic abnormalities , macro - albuminuria , \\n and smoking . \\n ( 2007 ) , in the same community investigated the effect of \\n periodontitis on overt nephropathy and end - stage renal disease ( esrd ) in a group of \\n 529 subjects with t2d , aged approximately 25 years old . after adjusting for age , sex , \\n diabetes duration , bmi , and smoking \\n , they found that periodontitis and edentulism \\n were significantly associated with the risk of overt nephropathy and esrd . \\n the \\n incidence of macro - albuminuria was 2.0 , 2.1 , and 2.6 times greater in individuals \\n with moderate or severe periodontitis or in those who were edentulous , respectively , \\n than those with none / mild periodontitis . \\n the incidence of esrd was also 2.3 , 3.5 , and \\n 4.9 times greater for individuals with moderate or severe periodontitis or for those \\n who were edentulous , respectively , than those with none / mild periodontitis . \\n the clinical and epidemiological evidence found in the literature we reviewed \\n provides support for the concept that dm can have adverse effects on pd , that pd \\n worsens in parallel with glycemic control and finally that pd is associated with an \\n increase in the risk for diabetes - related complications . \\n however , further \\n prospective , rigorous , controlled trials with a larger number of patients , in \\n ethnically diverse populations are warranted to establish these relationships and \\n that treating pd can positively influence glycemic control and possibly reduce the \\n burden of diabetes - related complications . \\n pd is a chronic bacterial infection that affects both the gingiva and the bone that \\n supports the teeth and is caused by anaerobic gram - negative microorganisms that are \\n present in the bacterial plaque that adheres to the teeth . \\n pd is a very prevalent condition . in the united states , over half the population aged \\n 18 years or more \\n have pd in its early stages , increasing to up to 75% after the age \\n of 35 years ; its mild to moderate forms are present in 30% to 50% , and the severe \\n generalized form in 5% to 15% of the general adult population . \\n pd has even higher prevalence in \\n minorities , in poor and developing countries and a considerable global \\n variation . \\n the presence of anaerobic gram - negative bacteria causes a local inflammatory response \\n that becomes chronic and progressive ; this inflammation of the gingiva causes \\n alveolar bone destruction and loss of the tissue attachment to the teeth , caused by \\n components of microbial plaque that have the capacity to induce an initial infiltrate \\n of inflammatory cells , such as lymphocytes , macrophages , and polymorphonuclear \\n leukocytes ( pmns ) . \\n some microbial components , especially lipopolysaccharide ( lps ) , activate macrophages \\n that synthesize and secrete a great variety and amount of pro - inflammatory molecules , \\n such as the cytokines interleukin-1 ( il-1 ) and tumor necrosis factor- ( tnf- ) ; \\n prostaglandins , especially prostaglandin e2 ( pge2 ) ; and some other enzymes . \\n bacterial toxins can also activate t lymphocytes to produce il-1 and lymphotoxin \\n ( lt ) , a molecule with properties that are similar to those of tnf-. these cytokines \\n show potent pro - inflammatory and catabolic activities , and have important roles in \\n periodontal tissue destruction caused by collagenolytic enzymes such as \\n metalloproteinases ( mmps ) . \\n these \\n collagenolytic enzymes are activated by reactive oxygen species and elevate the \\n levels of interstitial collagenase in inflamed gingival tissue . \\n the attachment loss deepens the sulcus , creating a periodontal pocket that contains \\n thousands of millions of bacterial cells . \\n this stage is the transition between \\n gingivitis and periodontitis , the most common pds . \\n when bacterial biofilms on the teeth are not disrupted on a regular basis , the \\n emergences of gram - negative anaerobic bacterial species activate several host \\n processes that will interfere in the extent and severity of the disease . \\n recently , many advances have occurred in the knowledge of the nature of the \\n infectious agents involved in pd . \\n approximately 500 different bacterial entities and \\n various human viruses have already been associated with the formation of dental \\n microbial plaque . \\n the most frequently recognized periodontal pathogens belong to three microaerophilic \\n species ( actinobacillus actinomycetemcomitans , campylobacter rectus , \\n and eikenella corrodens ) and seven anaerobic species \\n ( porphyromonas gingivalis , bacteroides forsythus , treponema denticola , \\n prevotella intermedia , fusobacterium nucleatum , eubacterium , and \\n spirochetes ) . \\n various herpes viruses , such as the human cytomegalovirus ( hcmv ) and epstein - barr \\n virus ( ebv-1 ) , have recently also emerged as pathogens in cases of destructive \\n pd . \\n many conditions can predispose and/or facilitate the occurrence of pd such as \\n smoking , genetic influences , estrogen \\n deficiency , estrogen \\n excess , \\n dyslipidemia and obesity . \\n this epidemic is also associated with an increased occurrence \\n of obesity - related diseases like hypertension , cardiovascular disease , metabolic \\n syndrome and dm that are also linked to pd . \\n dm encompasses a group of genetically and clinically heterogeneous metabolic \\n disorders characterized by hyperglycemia that results from a defective insulin \\n secretion and/or activity . \\n dm is classified according to its etiology as type 1 ( t1d ) , type 2 ( t2d ) , gestational \\n diabetes ( gdm ) and other specific types . \\n t1d results from the destruction of \\n beta - cells within the islets of langerhans of the pancreas , which results in a \\n complete insulin deficiency ; it can be immune - mediated or have an idiopathic \\n etiology . \\n t2d ranges from an insulin resistance which progresses into an insulin \\n deficiency due to a secondary failure in the pancreatic beta - cells . \\n gdm is defined as \\n any degree of glucose intolerance with onset or first recognition during pregnancy . \\n lastly , the category \" other specific types \" comprehends a group of several types of \\n dm with different etiologies . \\n developed countries have a higher prevalence of dm than developing countries and more \\n women than men are affected with dm . \\n the \\n prevalence of dm in adults all over the world was estimated to be around 4.0% and it \\n was expected to rise to 5.4% by the year 2025 . numerically it means a rise from 135 \\n million in 1995 to 300 million in the year 2025 . \\n an increase of 42% ( from 51 to 72 million ) is expected \\n in developed countries and an increase of 170% ( from 84 to 228 million ) in the \\n developing world . \\n therefore , it is expected that by the year 2025 , 75% of people with \\n dm will be living in developing countries where the majority of people with dm are \\n aged between 45 - 64 years old . in developed countries , \\n people with diabetes and with chronically poor metabolic control can experience \\n micro - vascular and macro - vascular complications leading to a significant burden for \\n the individual and for the society . \\n this burden includes direct costs of medical care \\n and indirect costs , such as loss of productivity , which result from diabetes - related \\n morbidity and premature mortality . \\n health care expenses for people with diabetes is more than two - times higher than the \\n expenses for people without diabetes ; the direct and indirect expenditures \\n attributable to diabetes in 2007 in the usa were estimated at us$174 billion , with \\n slightly more spent on chronic complications attributable to dm than properly on dm \\n care . \\n the international \\n diabetes federation estimated that dm costs account for 5 - 10% of the total healthcare \\n budget in many countries . in brazil , \\n the per capita total , direct medical , direct nonmedical \\n and indirect costs of patients with t1d were us$ 1,741.42 , us$ 1,319.15 , us$ 61.47 \\n and us$ 360.81 , respectively . \\n the total direct non - medical costs were us$ 195,461.54 , \\n spent with transportation for the patients and caregivers . \\n total annual costs for care of outpatients with t2d \\n were us$ 2,108 per patient , out of which us$ 1,335 per \\n patient of direct costs ( 63.3% ) and us$ 773 per patient of \\n indirect costs ( 36.7% ) . \\n patients with both micro - vascular and macro - vascular \\n complications had higher costs ( us$ 3,199 per patient ) compared to \\n those with either micro - vascular ( us$ 2,062 per patient ) or \\n macro - vascular ( us$ 2,517 per patient ) complications only . \\n the search conducted for this review used the bbo ( bibliografia brasileira de \\n odontologia ) , medline , lilacs and pubmed for controlled trials databases , in english \\n and portuguese languages published from 1960 to october 2012 . \\n primary research \\n reports on investigations of relationships between dm / dm control , pd / periodontal \\n treatment and pd / dm / diabetes - related complications identified relevant papers and \\n meta - analyses published in this period . \\n the identified reports are displayed in figures organized \\n according to the following groups : 1- the effects of dm on pd ; 2- the effects of \\n glycemic control on pd and 3-the effects of pd on glycemic control and on \\n diabetes - related complications . the studies listed in figure 1 compared \\n periodontal status in individuals with and without dm in the majority of the reports . \\n these studies were classified according to the study design , type of diabetes , sample \\n number , age range , evaluation of pd and other diabetes - related variables . \\n the \\n majority of the studies were cross - sectional ( 21/29 ) and limited in the possibility \\n of providing a causal - effect relationship . \\n effects of diabetes mellitus on periodontal disease pd= periodontal disease - dm = diabetes mellitus - t1d = diabetes mellitus type \\n 1 - t2d = diabetes mellitus type 2 - gdm = gestational diabetes mellitus the link between dm and the adverse effects on pd has been extensively \\n described . \\n we have found that 27 in 29 studies showed \\n supportive evidence of the adverse impact of dm on periodontal health . \\n there were four studies of t1d ; one study reported more extensive radiographic bone \\n loss in patients with t1d compared to the controls , lalla , et al . \\n ( 2006 ) in a case - control study found that periodontal \\n destruction can start very early in life in patients with t1d and becomes more \\n prominent as children become adolescents . in a population aged 4 to 33 years , cianciola , et \\n al . \\n ( 1982 ) reported a \\n significantly higher prevalence of pd in t1d than in non - diabetic siblings and \\n non - diabetic unrelated controls . \\n the prevalence of pd among 11- to 18-year - old \\n teenagers with dm was 9.8% as compared to 1.7% in controls without dm . \\n an accelerated \\n periodontal destruction was found in children and teens with dm , with poor metabolic \\n control . in an adult \\n population aged 40 - 69 years \\n , 58.4% of patients with long standing t1d exhibited \\n severe pd as opposed to 7.1% of controls without dm . \\n two \\n reports were comprised of patients aged 15 years or older , and \\n twelve included only adults . \\n twelve of these fourteen \\n studies reported significantly poorer periodontal health in subjects with t2d , \\n whereas a significantly poorer greater prevalence was found in one study and no significant difference was \\n found in another study . \\n six reports consist of analyses in which subjects with t1d and t2d were analyzed \\n together without distinction of diabetes type . four studies included children and \\n adolescents and another \\n five of these six studies reported greater \\n prevalence , extent , or severity of pd in subjects with dm . \\n one report did not \\n find significant differences in pd between subjects with and without dm when an \\n adequate metabolic control was found in the former group . regarding gdm , \\n one was conducted only with women with gdm \\n that were compared to a control group between the 34 - 36 gestation weeks . \\n the results of the study suggest that gingivitis seems to be more prevalent in women \\n with gdm compared to healthy pregnant women and the plaque accumulation seems to be \\n the main cause of gingival inflammation . \\n another study found that all types of dm increase the risk of \\n pd , including gdm . \\n two other \\n studies conducted in the usa collected data from over 4,000 women with a history of \\n gdm . \\n one report included ages 15 - 44 and the other , ages 20 - 59 . \\n pd was found in 45% of pregnant women with gdm \\n vs. 13% in the healthy pregnant women , with an adjusted odds \\n ratio of 9.11 . in non - pregnant women , \\n 40% of women with t1d or t2d , 25% of those with \\n a history of gdm , and 14% of healthy women had pd . \\n ( 2006 ) found the \\n prevalence of pd to be higher in women with a history of gdm and concluded that these \\n women may be at greater risk for developing more severe pd , than women without a \\n history of gdm . \\n finally , taylor \\n ( 2001 ) and mealey ( 2006 ) in two \\n extensive literature reviews found a bidirectional interrelationship between all \\n types of dm , including gdm and pd . \\n two of these studies included subjects with t1d exclusively , seven studies subjects \\n with t2d exclusively and five a combination of subjects with either t1d , t2d , gdm and \\n others ( figure 2 ) . \\n one prospective study \\n conducted with t1d did not show any association between the degree of glycemic \\n control and pd but a positive association with local oral hygiene measures , and another study , that was \\n cross - sectional , has regarded this association . \\n five of the seven reports published regarding the \\n association between glycemic control and pd in t2d have found this \\n association and two did not . \\n we have found five studies providing \\n information on the differences in periodontal health in groups of mixed types of \\n diabetes ; three have found this association and two did not . among these fourteen studies , \\n eleven were cross - sectional that \\n imposes some limitations on the cause - effect inference ; two were prospective and one \\n was an extensive literature review . \\n otherwise , nine of these reports support the \\n evidence of greater prevalence , extent and severity of pd and also provide evidence \\n that glycemic control worsens in parallel with the worsening of pd . \\n substantial evidence has been demonstrating dm as a risk factor for the impairment of \\n periodontal health and a growing body of evidence has been supporting pd as having an \\n adverse effect on glycemic control and on the pathophysiology of diabetes - related \\n complications . \\n the inflamed periodontal tissue may serve as a chronic source of \\n bacteria , bacterial products and many inflammatory mediators such as tnf- , il6 , and \\n il1 that have been shown to have important effects on lipid and glucose \\n metabolism and have also been reported to be \\n insulin antagonists and related to insulin resistance that is predominantly found in \\n t2d and gdm . as shown in figure 3 , data interpretation is \\n often confounded by varying definitions of dm and pd and different clinical criteria \\n applied to determine the prevalence , extent , severity of pd , levels of glycemic \\n control and diabetes - related complications ; there is also marked heterogeneity in the \\n studies \\' designs , conduct , length of follow - up , types of participants , and \\n periodontal treatment protocols . \\n effects of periodontal disease on glycemic control and diabetes - related \\n complications abbreviations : rct , randomized controlled trial ; non - rct , non - randomized \\n controlled trial - treatment study ; d , days ; wk , weeks ; m , months ; y , years ; \\n hba1 c , glycated hemoglobin - pd= periodontal disease - dm = diabetes mellitus \\n - t1 d = diabetes mellitus type 1 - t2d = diabetes mellitus type 2 - \\n gdm = gestational diabetes mellitus evidence regarding the effects of pd on glycemic control comes from observational and \\n treatment studies ( figure 3 ) . \\n the treatment \\n studies are a set of reports that include ten randomized clinical trials ( rcts ) , \\n twelve non - rcts , four meta - analyses , one literature review , one longitudinal study , \\n one transversal study , one retrospective study , one prospective study and two \\n clinical cases discussions . the rcts used control groups that were either treated controls , non - treated controls \\n or controls that did not change their usual dental care . \\n among the ten rcts , eight \\n reported a beneficial effect for periodontal therapy and two did not . \\n one of the rcts , recently conducted , \\n showed significant improvement in hba1c levels but did not result in a statistically \\n significant improvement in serum levels of inflammatory markers such as hs - crp , \\n d-8-iso , mmp-2 and mmp-9 . \\n an important source of variation in the rcts is the use of antibiotics with the \\n non - surgical periodontal therapy . \\n this fact brings a lot of confusion in the \\n interpretation of the results of these trials in such a way , that to date , there is \\n no clear evidence to support a requirement for the use of antibiotics in combination \\n with non - surgical periodontal treatment in order to observe an improvement in \\n glycemic control associated with periodontal therapy . among the group of twenty - three periodontal treatment studies that were not rcts , \\n like the rcts , there was marked variation in the \\n use of adjunctive antibiotics , with six of the eight studies that used systemic \\n antibiotics reporting a beneficial effect on glycemic control . \\n additional evidence to support the effect of severe periodontitis on increased risk \\n for poorer glycemic control comes from two longitudinal observational studies . \\n a \\n longitudinal epidemiological study of the pima indians in arizona , usa , which present \\n the world \\'s highest reported prevalence of dm , found that subjects with t2d in good to moderate control and \\n with severe periodontitis at baseline were approximately six times more likely to \\n have poor glycemic control at a 2-year follow - up than those without severe \\n periodontitis at baseline . \\n ( 1998 ) in another \\n observational study of 25 adults with t2d , aged 58 - 77 years , also reported an \\n association between advanced periodontal disease and impaired metabolic \\n control . \\n recently , some important trials have recognized that poor glycemic control is a major \\n determinant for the development of the chronic complications of dm . \\n the diabetes \\n control and complications trial , the epidemiology of diabetes interventions and \\n complications ( edic ) trial , the long - term follow - up study of the dcct , both conducted \\n with t1d and the united kingdom prospective diabetes study ( ukpds ) conducted with \\n t2d , demonstrated that attaining and maintaining good glycemic control could reduce \\n the risk for and/or postpone the progression of micro - vascular complications in \\n patients with t1d and t2d . \\n initially , the ukpds observed a statistically non significant 16% reduction ( p=0.052 ) \\n in the risk of combined fatal or nonfatal myocardial infarction and sudden death . \\n recently , it was observed that a long - standing good metabolic control can bring \\n significant long - term consequences including the reduction in the risks of fatal or \\n nonfatal myocardial infarction and sudden death . \\n the epidemiological analysis from \\n the ukpds showed a continuous association between the risk of cardiovascular \\n complications and glycemic control ; every percentage point decrease in hba1c , was \\n associated with a 25% reduction in diabetes - related deaths , 7% reduction in all - cause \\n mortality , and a 18% reduction in combined fatal and nonfatal myocardial \\n infarction . \\n some observational studies regarding the association between pd and the risk for dm \\n complications have given strong evidence for this association . in a study conducted \\n in sweden , with 39 case - control pairs of individuals with t1d and t2d for a median \\n follow - up time of six years , thorstensson , et al . \\n ( 1996 ) observed a significantly higher prevalence \\n of proteinuria and cardiovascular complications such as stroke , transient ischemic \\n attacks , angina , myocardial infarction and intermittent claudication in the case \\n group than in controls . \\n these findings suggest that an association between renal \\n disease , cardiovascular disease and its complications and severe periodontitis seems \\n to exist . \\n ( 2005 ) , studied \\n the contribution of pd to the mortality associated with t2d in the gila river indian \\n community in arizona , usa , on behalf of the national institute of diabetes and \\n digestive and kidney diseases , addressing nephropathy and cardiovascular disease . \\n this was a prospective longitudinal study with a cohort of 628 individuals , aged \\n approximately 35 years old , for a median follow - up of eleven years ( range 0.3 to 16 ) . \\n during the study period \\n individuals with severe pd had 3.2 times \\n greater risk for cardio - renal mortality ( i.e. , ischemic heart disease and diabetic \\n nephropathy combined ) compared with the reference group ( no , mild , or moderate pd \\n combined ) , after adjustment for several major risk factors of cardio - renal mortality \\n such as age , sex , diabetes duration , hba1c , body mass index ( bmi ) , hypertension , \\n blood glucose , cholesterol , electrocardiographic abnormalities , macro - albuminuria , \\n and smoking . \\n ( 2007 ) , in the same community investigated the effect of \\n periodontitis on overt nephropathy and end - stage renal disease ( esrd ) in a group of \\n 529 subjects with t2d , aged approximately 25 years old . after adjusting for age , sex , \\n diabetes duration , bmi , and smoking \\n , they found that periodontitis and edentulism \\n were significantly associated with the risk of overt nephropathy and esrd . \\n the \\n incidence of macro - albuminuria was 2.0 , 2.1 , and 2.6 times greater in individuals \\n with moderate or severe periodontitis or in those who were edentulous , respectively , \\n than those with none / mild periodontitis . \\n the incidence of esrd was also 2.3 , 3.5 , and \\n 4.9 times greater for individuals with moderate or severe periodontitis or for those \\n who were edentulous , respectively , than those with none / mild periodontitis . \\n the clinical and epidemiological evidence found in the literature we reviewed \\n provides support for the concept that dm can have adverse effects on pd , that pd \\n worsens in parallel with glycemic control and finally that pd is associated with an \\n increase in the risk for diabetes - related complications . \\n however , further \\n prospective , rigorous , controlled trials with a larger number of patients , in \\n ethnically diverse populations are warranted to establish these relationships and \\n that treating pd can positively influence glycemic control and possibly reduce the \\n burden of diabetes - related complications .', 'output': 'periodontal disease ( pd ) is one of the most commonly known human chronic disorders . \\n the relationship between pd and several systemic diseases such as diabetes mellitus \\n ( dm ) has been increasingly recognized over the past decades.objective:the purpose of this review is to provide the reader with knowledge concerning the \\n relationship between pd and dm . \\n many articles have been published in the english \\n and portuguese literature over the last 50 years examining the relationship \\n between these two chronic diseases . \\n data interpretation is often confounded by \\n varying definitions of dm , pd and different clinical criteria were applied to \\n determine the prevalence , extent and severity of pd , levels of glycemic control \\n and diabetes - related complications.methods:this paper provides a broad overview of the predominant findings from research \\n conducted using the bbo ( bibliografia brasileira de odontologia ) , medline , lilacs \\n and pubmed for controlled trials databases , in english and portuguese languages \\n published from 1960 to october 2012 . \\n primary research reports on investigations of \\n relationships between dm / dm control , pd / periodontal treatment and \\n pd / dm / diabetes - related complications identified relevant papers and meta - analyses \\n published in this period.results:this paper describes the relationship between pd and dm and answers the following \\n questions : 1- the effect of dm on pd , 2- the effects of glycemic control on pd and \\n 3- the effects of pd on glycemic control and on diabetes - related \\n complications.conclusions:the scientific evidence reviewed supports diabetes having an adverse effect on \\n periodontal health and pd having an adverse effect on glycemic control and on \\n diabetes - related complications . \\n further research is needed to clarify these \\n relationships and larger , prospective , controlled trials with ethnically diverse \\n populations are warranted to establish that treating pd can positively influence \\n glycemic control and possibly reduce the burden of diabetes - related \\n complications .', '__index_level_0__': 30489}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': \"type 1 diabetes ( t1d ) is characterized by immune - mediated destruction of the insulin - secreting  cells in the pancreatic islets as a result of an unknown trigger mechanism . \\n it is , however , well known that development of clinical disease is preceded by an asymptomatic latent period during which immune reactions against the insulin - secreting cell autoantigens can be demonstrated [ 13 ] . in this context , biochemically detectable autoantibodies against insulin ( iaa ) , glutamic acid decarboxylase ( gada ) , insulinoma - associated antigen 2 ( ia-2a ) , and zn - transporter 8 ( znt8a ) as well as their counterpart immunofluorescent anti - islet antibodies ( ica ) serve as reliable biomarkers for t1d development . \\n specifically , knip et al .   demonstrated that all children initially testing positive for both gada and ia-2a progressed to clinical t1d over a 26-year followup . over the last few decades the incidence of t1d has dramatically increased in many countries particularly in early childhood , suggesting that an event associated with progression towards t1d disease was occurring early in life . \\n an increasing number of studies have suggested that the composition of the intestinal microbiota might contribute significantly to the development of disorders such as t1d since changes to the microflora mirror changes in general life styles and the social system [ 46 ] . \\n it is believed that intestinal colonization with certain bacteria strongly influences systemic immune responses early in life and may play a significant role in modulating the development of various chronic diseases . \\n some of the most common constituents of the gastrointestinal tract microbiota include bifidobacterium and lactobacillus species that have been shown to play a significant role in the development of immune - mediated disorders in humans [ 811 ] . \\n that is , predominant colonization with b. adolescentis has been reported in patients with allergic disorders compared to colonization patterns observed in individuals with nonallergic disorders [ 1214 ] . \\n other bifidobacterium species have been shown to have diverse effects , including variable associations of b. longum with immune - mediated and inflammatory diseases . \\n studies of rodent disease models [ 15 , 16 ] have also identified differences in the ability of different bifidobacterium species in modulating immune reactivity and inflammation . \\n most well known are the effects of the probiotic strain l. rhamnosus gg in preventing atopic eczema among infants , possibly by modulating the immune response to allergens . \\n the recent identification of the l. rhamnosus gg p40 molecule as an immunomodulator   represents a significant step forward towards resolving problems related to the effects of probiotics in vivo . \\n previously we demonstrated that the elicitation of antibodies against l. acidophilus antigenic components differed between children with various chronic diseases . \\n the current study describes experiments designed to extend these observations by investigating the prevalence of serum antibodies against b. adolescentis , b. longum , and l. rhamnosus gg in young children that developed or did not develop t1d . \\n plasma samples ( n = 107 ) from 38 children participating in the finnish type 1 diabetes prediction and prevention ( dipp ) study and born between 1995 and 2003 were included in this study . \\n children were separated into 2 groups of 19 children ( 11 females ) each matched for age and sex . \\n one group was comprised of children who later developed at least 2 t1d - related autoantibodies and subsequently clinical t1d ( islet autoimmunity [ ia ] , i.e. , the ia - positive group ) and the other group was comprised of children that did not develop or present with signs of islet autoimmunity ( ia - negative group ) and without t1d during followup . \\n islet autoimmunity was defined in this context as detection of at least 2 antibodies out of gada ( assay sensitivity 82% , specificity 96% ) , ia-2a ( assay sensitivity 72% , specificity 100% ) , and/or ica . \\n levels of ica were measured by an indirect immunofluorescence assay with a detection limit of 2.5 juvenile diabetes foundation units . \\n all children in the ia - positive group later developed t1d ( age at onset ranged between 2.4 and 10.3 years ) . \\n both groups were similar in their documented use of antibiotics ( during the first 2 years of life 13/18 ia - positive children and 17/18 ia - negative children were treated with antibiotics ; \\n p = 0.177 ; the data pertaining to one child from each group was not available ) . \\n no differences in the use of probiotics between groups were observed ( 2 children from the ia - positive group ; p = 0.487 ) . \\n wilkins - chalgren agar ( oxoid , uk ) was used to culture b. adolescentis dsm 20083 ( atcc 15703 ) and dsm 20086 ( atcc 15705 ) and b. longum dsm 20088 ( atcc 15697 ) . \\n man - rogosa - sharpe agar ( oxoid , uk ) was used to culture l. rhamnosus gg . \\n wilkins - chalgren agar plates were incubated in an anaerobic cabinet ( concept , uk ; with gas mixture of 5% co2 , 5% h2 , and 90% n2 ) and man - rogosa - sharpe agar in a microaerobic environment ( joan , france ) with a gas mixture of 10% co2 for 48  h. bacterial cells were collected , suspended in phosphate - buffered saline solution ( pbs , ph = 7.4 ) , and washed 3 times with the same buffer . \\n subsequently , cells were disrupted with 0.1  mm glass beads ( biospec products , usa ) in pbs in the presence of complete protease inhibitors ( boehringen mannheim - roche , switzerland ) on ice . \\n the total protein concentration in lysates was determined using the protein assay solution ( bio - rad , usa ) using bovine serum albumin as a standard and kept in aliquots at 20c until used . \\n preparations were mixed with 300  l sds - page sample buffer and heated for 15  min at 95c . \\n the proteins in the bacterial cell lysate were loaded on a 520% gradient gel with a 5% concentrating gel with all blue 10250  kda molecular weight ( mw ) markers ( bio - rad , usa ) as standards and separated by electrophoresis using a current of 40  ma and a voltage of 200 v for 6  h using a vertical electrophoresis system se-600 ( hoefer , usa ) connected to a thermostatic circulator . \\n separated proteins were transferred onto a polyvinylidene difluoride ( pvdf ) membrane ( 0.45  m pore size ) using a semidry electroblotter ( hoefer , usa ) at a current density of 1  ma / cm for 1.5  h and membranes blocked as described by nilsson et al . . \\n five mm wide strips were cut from the membrane and incubated with plasma samples diluted to 1  :  50 for iga and igm and 1  :  100 for igg in the incubating buffer   overnight at 4c . \\n strips were then incubated with either secondary anti - human iga , anti - human igm , or anti - human igg antibodies labelled with horse - radish peroxidase ( hrp ) ( diluted 1  :  500 ; dako , denmark ) for 1  h and subsequently developed in substrate solution comprised of 0.04% carbazole in 50  mm sodium acetate buffer ( ph = 5.0 ) and hydrogen peroxide ( 0.015% ) for 30  min at room temperature . \\n the strips were scanned using a bio - rad gs-710 imaging densitometer ( bio - rad , usa ) . \\n the relative mw of the bands was estimated with the bio - rad quantity one image analysis software ( bio - rad , usa ) according to the all blue molecular weight markers . \\n the f - test was used to compare the frequency of antibodies in the two groups . \\n we first analyzed the dynamics of igg antibodies that developed against l. rhamnosus gg target antigens in children between 3 and 24 months of age . \\n this approach was chosen due to the frequent consumption of the probiotic l. rhamnosus gg - containing dairy products by children and adults in finland . \\n we discovered 25 clearly distinguishable l. rhamnosus gg antigenic proteins ranging between 11 and 86  kda ( table 1 ) . \\n the number of l. rhamnosus gg proteins recognized by igg increased steadily with age . \\n children between the ages of 12 and 24 months presented with significantly more antibodies against 5/9 ( 31 , 42 , 45 , 47 , and 49  kda proteins ) selected highly reactive proteins compared to reactivity observed in 3-month - old infants . however , no significant differences in igg reactivity were observed in response to l. rhamnosus gg antigens between ia - positive and ia - negative children . \\n the average number of igg - reactive l. rhamnosus gg protein bands was 10.5  6.6 in ia - positive infants ( between 5 and 17 bands ) and 11.5  7.2 in ia - negative children ( between 5 and 20 bands ) at 12 months of age . based on these results \\n the 12-month - old group was chosen for further analysis of immune reactivity against bifidobacterium spp \\n igg bound to bifidobacterium antigens in the molecular weight ranging from 7  kda to 131  kda . \\n the number of proteins recognized varied between strains with the greatest number of reactive antigens observed for b. longum dsm 20088 ( n = 57 ; table 1 ) . the average number of igg - reactive proteins in assays with b. adolescentis dsm 20083 , b. adolescentis dsm 20086 , and b. longum dsm 20088 strains was not significantly different between ia - positive children and ia - negative subjects ( figures 13 ) . \\n iga bound to protein antigens in the molecular weight ranging from 7  kda to 104  kda ( table 1 ) . similar to the igg antibody results , more b. longum dsm 20088 proteins were recognized by iga than any other tested bacteria . \\n the average number of b. adolescentis dsm 20083 proteins bound by iga was lower than the number of proteins bound from other strains . \\n there was a significant difference in the number of proteins reactive to antibodies between the 2 groups of children : 1.9  2.6 reactive protein bands in ia - positive infants and 1.2  1.2 reactive protein bands in ia - negative children ( p < 0.003 ; figure 1 ) . \\n also in tests with bifidobacterium strains the average number of reacting antigenic proteins tended to be at a higher frequency in the ia - positive group compared to the ia - negative group ( figures 2 and 3 ) . \\n igm bound to bacterial proteins in the molecular weight ranging from 13  kda to 84  kda . \\n the average number of igm reacting protein bands in both assays either with b. adolescentis dsm 20083 or with b. adolescentis dsm 20086 was higher in ia - positive than in ia - negative infants , but this difference was not statistically significant ( p = 0.235 and p = 0.285 , resp . ; \\n this study investigated the reactivity of serum antibodies against the probiotic strain l. rhamnosus gg and selected natural bifidobacterium spp . \\n proteins in children 3 , 6 , 12 , and 24 months of age using an immunoblot assay developed previously by our group . \\n l. rhamnosus gg is included into the most commonly used dairy products in finland , whereas all chosen bifidobacterium strains , b. adolescentis dsm 20083 , b. adolescentis dsm 20086 , and b. longum dsm 20088 , are usual inhabitants of the intestinal microbiota . \\n the colonization of newborns with microbes begins during delivery and by 2 months of age 91% of infants are colonized with b. longum , 75% with b. adolescentis , and 57% with lactobacilli group \\n i ( l. rhamnosus , l. casei , and l. paracasei ) . a shift in colonization with b. adolescentis strains towards earlier \\n life has been demonstrated recently   and this has also been observed at the age of 5 years . \\n the population studied here was obtained from the finnish dipp study and divided into 2 groups based on the development of diabetes - associated autoantibodies and t1d over a 10-year followup . \\n immunoblot analyses of bacterial lysates demonstrated a substantial increase in the frequency of igg antibody reactivity to l. rhamnosus gg proteins between 6 and 12 months of age , showing that the most conspicuous increase in antibody production occurred before the age of 12 months . in spite of these age - dependent changes , reactions against l. rhamnosus gg proteins \\n were seen in ia - positive and ia - negative subjects at a similar frequency . \\n this result indicated that igg antibodies reactive to probiotic strain l. rhamnosus gg proteins were not suggestive of progression toward -cell autoimmunity or development of t1d in children . \\n the most important observation made from immunoblot assays testing antibody reactivity to l. rhamnosus gg proteins was the age - related dynamics associated with the development of circulating antibodies to microbial proteins . \\n proteins since these organisms are known to colonize the infant 's gut early in life . \\n we assessed binding to different antigenic proteins from b. adolescentis dsm 20083 , b. adolescentis dsm 20086 , and b. longum dsm 20088 by igg , iga , and igm class antibodies and observed that iga bound significantly more b. adolescentis dsm 20083 strain antigens in children who developed islet autoimmunity and t1d later in life . at the same time we could not find any significant differences between the two groups of children in the frequencies of igg or iga antibodies against other bifidobacteria strains \\n it is noteworthy that we found that b. longum proteins were recognized by igg and iga antibodies to a substantially higher extent compared to other bacteria studied . \\n this phenomenon may indicate a stronger stimulation of the infant 's immune system by b. longum protein antigens \\n . some of the immunoreactive bands detected may be due to cross - reactive antibodies that developed in response to bacterial antigens from species not used in this study . \\n it is however very difficult to make this distinction since we presently have no tools ( monoclonal antibodies ) to discriminate between strain - specific reactivity and cross - reactivity . \\n regardless , it was clear that differences in the development of iga antibodies with reactivity against b. adolescentis dsm 20083 ( atcc 15703 ) antigens were present independent of the mechanism involved . \\n it is of particular importance to note that differences between the 2 groups were associated with reactivity by iga but not igg or igm class antibodies . \\n iga with reactivity against commensal intestinal microbes can develop as a consequence of colonization with high numbers of organisms at the mucosal surface . \\n it has been shown that oral administration of the probiotic mixture vsl#3 that includes 8 different probiotic strains ( including 3 bifidobacteria strains ) prevented the development of autoimmune diabetes in nonobese diabetic mice . \\n different bifidobacteria strains have clearly been shown to have variable influences on immune responses [ 23 , 24 ] . \\n the species of b. adolescentis most commonly isolated from allergic children has been shown to more effectively trigger the production of proinflammatory cytokines compared to other strains of bifidobacteria [ 25 , 26 ] supporting our results that demonstrated differences between children with and without signs of -cell autoimmunity with regard to reactivity to b. adolescentis strain 20083 antigens which might impact t1d development . \\n whether these differences are in some way linked to differences in the microbiome needs further studies [ 27 , 28 ] . in conclusion , during the first year of life the immune system starts to produce antibodies which recognize antigens produced by organisms comprising the normal microbiota . \\n although some of these proteins may contain common antigenic epitopes present on proteins produced by various bacteria , our current study showed that differences in antibody reactivities could be found even between the same species of b. adolescentis . \\n these differences might reflect a propensity for developing t1d confirming recent findings regarding differences in the gut microbiome between children affected and unaffected by t1d . \\n further studies will be needed to verify how the presence of this particular b. adolescentis dsm 20083 strain in the intestine of children is involved in predisposing individuals to developing -cell autoimmunity and t1d .\", 'output': 'the intestinal microbiota is essential to the maturation and homeostasis of the immune system . \\n immunoblot assays were used to establish the prevalence of serum igg , igm , and iga antibodies specific for bifidobacterium adolescentis , bifidobacterium longum , and lactobacillus rhamnosus gg proteins in young children presenting with or without type 1 diabetes ( t1d ) . \\n we demonstrated that children between the ages of 6 and 12 months had a substantial increase in the frequency of igg antibodies specific for l. rhamnosus gg proteins . \\n we measured igg , igm , and iga class antibody reactivity against b. adolescentis dsm 20083 , b. adolescentis dsm 20086 , and b. longum dsm 20088 proteins demonstrating significantly higher iga responses against b. adolescentis dsm 20083 strain proteins in children who developed islet autoimmunity and t1d later in life . \\n b. adolescentis strains showed more igm type antibodies in children who developed t1d later in life , but the difference was not statistically significant . \\n b. longum proteins were recognized by igg and iga antibodies to a higher extent compared to other bacteria studied . \\n these results confirm that differences in immune reactivity against some commensal strains in young children may represent a different risk factor for developing t1d .', '__index_level_0__': 30474}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'annually , falls occur in about one third of community - dwelling adults aged 65 and older living in the us.1 the physical and functional impacts ( fractures , soft - tissue injury , premature institutionalization , and deaths ) of falls have been well documented , but little is known about the long - term emotional and cognitive impact of falls.26 also , falls , depression , and cognitive impairments frequently coexist in the same patient , raising the possibility of shared risk factors and shared etiology . preventing falls - related \\n disability requires a good understanding of how experience of falls affects subsequent emotional and cognitive function . \\n such understanding can inform development of interventions to stem the onset of not only physical disability but any fall - related cognitive disability . \\n falls , depression , and cognitive impairment shared common risk factors.3,5,712 past studies showed a relationship between cognitive impairment and falls,3,8,9 cognitive impairment and depression,10 and falls and depression.6,11,12 however , the synergistic relationship among these three syndromes has not been explored in depth . \\n raji et al found an association between lower scores on the mini mental state examination ( mmse ) and high depressive symptomatology in older mexican americans.10 a later study of the effects of cognitive and emotional status on physical functioning found that having high depression and low cognition was associated with poor physical performance.13 in another study of 283 adults aged 60 and older , biderman et al determined that the common risk factors for falls and depression are poor self - rated health , poor cognitive status , impaired ability to perform activities of daily living , two or more clinic visits in the past month , and slow walking speed.14 another explanation for the complex relationships among falls , depression , and cognitive decline may be due to subsequent events following development of one of the conditions . \\n . falls in older persons have been associated with development of fear of falls,15 with a subsequent decrease in levels of physical activity , walking , participation in social activities , and an increase in loneliness and social isolation.1519 over time , reduced social and physical activity may lead to onset of depression and future cognitive decline.2022 we wanted to explore this hypothesis further by testing whether , in a group of cognitively intact elders , recurrent falls would be independently associated with faster cognitive decline , and whether presence of depression would at least in part mediate this association . because of the high prevalence of depressive symptoms and cognitive impairments in older mexican american adults,11,23,24 a fast growing segment of the us population , we wanted to test whether having a fall would trigger social isolation , depression , and subsequent worsening of cognition . to avoid the floor effects of the mmse \\n , we chose to include only those with normal baseline cognition ( mmse 21 ) , a cut - off point recommended in populations with low educational attainment.25 mean education of our sample was 6.3 years . understanding the fall - cognition pathway is key to designing interventions that address all the potential pathways to cognitive and motor \\n first , we examined the association of falls versus no falls on subsequent change in cognitive function ( using the mmse ) over a 6-year period in a community sample of older mexican americans who were initially cognitively normal . \\n second , because past research has shown an association between depression and cognitive decline,10 we tested whether depressive symptoms would have a mediating effect on the association between falls and cognitive change . \\n data are from the h - epese ( hispanic established populations for epidemiologic studies of the elderly ) , an ongoing longitudinal study of mexican americans 65 years and older who reside in texas , colorado , california , new mexico , and arizona , usa.23 in - home interviews were conducted of 3,050 participants or their proxy at the beginning of the study ( 19931994 ) . \\n the sampling procedure assured a sample that is generalizable to approximately 500,000 older mexicans americans living in the southwest and has been described elsewhere.23 data were collected during home visits by trained interviewers in the language of the subject s choice ( spanish or english ) . \\n the face - to - face interviews included questionnaires , interviews , and physical assessments . the present study used participants interviewed in 20042005 ( wave 5 ) , 20072008 ( wave 6 ) , and 20102011 ( wave 7 ) . \\n wave 5 in this study is considered as baseline with two follow - ups ( wave 6 and wave 7 ) . \\n we excluded those with a mmse score < 21 ( n=681)25 because we were interested in examining how falls and high depressive symptoms influenced changes in cognitive function in those with normal or high cognition . also , we excluded those with missing information on the mmse ( n=199 ) . \\n participants with missing information on the mmse and those with mmse < 21 were significantly more likely to be older , have low level of education , perform lower in hand grip strength , report less hypertension , and report more stroke , hip fracture , high depressive symptoms , and falls compared with those with mmse 21 . after excluding participants with an mmse score < 21 at baseline and those with missing data on mmse , fall status , and all covariates , the final sample consisted of 1,119 participants . \\n subjects excluded were significantly more likely to be older , unmarried , and to have reported more hypertension , stroke , hip fractures , and high depressive symptoms . they were also more likely to have less education , a lower mmse score , and have had two or more falls . \\n fall status was established by asking the participants at each interview the following question :  during the last 12 months , how many times did you fall and land on the floor or ground ?  fall status was categorized as having no falls , having one fall , or having two or more falls . \\n scored on a 30-point scale , the mmse screens for difficulties in episodic memory , orientation , working memory , naming , language , and image copying.26,27 higher scores indicate better cognition . \\n interviewers were thoroughly trained in administering and scoring the mmse , through both workshops and videotaped instruction . \\n the english and spanish versions of the mmse were adopted from the diagnostic interview scale used in prior community surveys.28 this spanish version of the mmse has met standard criteria for development of translated tests , including formal translation , back - translation , and consensus by committee for final item content . \\n additionally , the spanish mmse has been successfully used in community surveys of mexican americans.29 baseline sociodemographic variables included age , sex , marital status , and years of education . \\n the presence of various medical conditions was determined with a series of questions asking participants if a doctor had ever told them that they had diabetes , heart attack , stroke , or hypertension . \\n depressive symptomatology was measured with the center for epidemiologic studies depression scale.30 this scale consists of 20 items that ask how often specific symptoms were experienced during the past week ; responses were scored on a 4-point scale ( ranging from rarely or none of the time to most or all of the time : 0 , 1 , 2 , 3 ) with potential total scores ranging 060 . \\n as is common in the literature , we consider persons scoring 16 or over to experience high depressive symptomatology.10,11,30 \\n data are from the h - epese ( hispanic established populations for epidemiologic studies of the elderly ) , an ongoing longitudinal study of mexican americans 65 years and older who reside in texas , colorado , california , new mexico , and arizona , usa.23 in - home interviews were conducted of 3,050 participants or their proxy at the beginning of the study ( 19931994 ) . \\n the sampling procedure assured a sample that is generalizable to approximately 500,000 older mexicans americans living in the southwest and has been described elsewhere.23 data were collected during home visits by trained interviewers in the language of the subject s choice ( spanish or english ) . \\n the face - to - face interviews included questionnaires , interviews , and physical assessments . the present study used participants interviewed in 20042005 ( wave 5 ) , 20072008 ( wave 6 ) , and 20102011 ( wave 7 ) . \\n wave 5 in this study is considered as baseline with two follow - ups ( wave 6 and wave 7 ) . \\n we excluded those with a mmse score < 21 ( n=681)25 because we were interested in examining how falls and high depressive symptoms influenced changes in cognitive function in those with normal or high cognition . also , we excluded those with missing information on the mmse ( n=199 ) . \\n participants with missing information on the mmse and those with mmse < 21 were significantly more likely to be older , have low level of education , perform lower in hand grip strength , report less hypertension , and report more stroke , hip fracture , high depressive symptoms , and falls compared with those with mmse 21 . after excluding participants with an mmse score < 21 at baseline and those with missing data on mmse , fall status , and all covariates , the final sample consisted of 1,119 participants . \\n subjects excluded were significantly more likely to be older , unmarried , and to have reported more hypertension , stroke , hip fractures , and high depressive symptoms . they were also more likely to have less education , a lower mmse score , and have had two or more falls . \\n fall status was established by asking the participants at each interview the following question :  during the last 12 months , how many times did you fall and land on the floor or ground ?  fall status was categorized as having no falls , having one fall , or having two or more falls . \\n scored on a 30-point scale , the mmse screens for difficulties in episodic memory , orientation , working memory , naming , language , and image copying.26,27 higher scores indicate better cognition . \\n interviewers were thoroughly trained in administering and scoring the mmse , through both workshops and videotaped instruction . \\n the english and spanish versions of the mmse were adopted from the diagnostic interview scale used in prior community surveys.28 this spanish version of the mmse has met standard criteria for development of translated tests , including formal translation , back - translation , and consensus by committee for final item content . \\n additionally , the spanish mmse has been successfully used in community surveys of mexican americans.29 baseline sociodemographic variables included age , sex , marital status , and years of education . \\n the presence of various medical conditions was determined with a series of questions asking participants if a doctor had ever told them that they had diabetes , heart attack , stroke , or hypertension . \\n depressive symptomatology was measured with the center for epidemiologic studies depression scale.30 this scale consists of 20 items that ask how often specific symptoms were experienced during the past week ; responses were scored on a 4-point scale ( ranging from rarely or none of the time to most or all of the time : 0 , 1 , 2 , 3 ) with potential total scores ranging 060 . \\n as is common in the literature , we consider persons scoring 16 or over to experience high depressive symptomatology.10,11,30 \\n fall status was established by asking the participants at each interview the following question :  during the last 12 months , how many times did you fall and land on the floor or ground ?  fall status was categorized as having no falls , having one fall , or having two or more falls . \\n scored on a 30-point scale , the mmse screens for difficulties in episodic memory , orientation , working memory , naming , language , and image copying.26,27 higher scores indicate better cognition . \\n interviewers were thoroughly trained in administering and scoring the mmse , through both workshops and videotaped instruction . \\n the english and spanish versions of the mmse were adopted from the diagnostic interview scale used in prior community surveys.28 this spanish version of the mmse has met standard criteria for development of translated tests , including formal translation , back - translation , and consensus by committee for final item content . \\n baseline sociodemographic variables included age , sex , marital status , and years of education . \\n the presence of various medical conditions was determined with a series of questions asking participants if a doctor had ever told them that they had diabetes , heart attack , stroke , or hypertension . \\n depressive symptomatology was measured with the center for epidemiologic studies depression scale.30 this scale consists of 20 items that ask how often specific symptoms were experienced during the past week ; responses were scored on a 4-point scale ( ranging from rarely or none of the time to most or all of the time : 0 , 1 , 2 , 3 ) with potential total scores ranging 060 . \\n as is common in the literature , we consider persons scoring 16 or over to experience high depressive symptomatology.10,11,30 \\n chi - square , analysis of variance , and post hoc tukey s tests were used to examine the distribution of covariates for participants by fall status at baseline . \\n general linear mixed models using the mixed procedure in sas ( sas institute , inc . \\n , cary , nc , usa ) were used to examine the factors associated with decline in cognitive function over a 6-year period as a function of fall status . \\n all variables were analyzed as time - dependent covariates ( potential to change as time progresses ) except age , sex , and education . \\n the mixed model was chosen for analysis because it best handles unbalanced data , allowing for modeling of both the time - dependent change in variables as well as the time - dependent change in the magnitude of association between variables . \\n in addition , because h - epese data comprised repeated measures over 6 years , mixed models allowed more flexibility in modeling the effects of time on outcome.31,32 three mixed models were constructed to test the relationship between fall status and cognitive decline over a 6-year period . model 1 included time , age , sex , marital status , years of formal education , and fall status . in model 2 , depressive symptomatology was added to the variables in model 1 . \\n medical conditions ( stroke , heart attack , hypertension , and diabetes ) were added to variables in model 3 . \\n models 2 and 3 were performed to test whether high depressive symptoms mediate the relationship between falls and cognitive decline ( model 2 ) and to test whether the relationship between falls and cognitive decline remains statistically significant after adjusting for all covariates ( model 3 ) . \\n all analyses were performed using the sas system for windows , version 9.2 ( sas institute , inc . ) . \\n at baseline , the mean age for the 1,119 participants was 80.8 years ( range , 74109 ) . sixty percent of the participants were female , 45.6% were married , and the mean years - of - education was 6.3 years ( range , 017 ) . \\n sixty five percent of participants reported hypertension , 32.9% diabetes , 14.9% heart attack , 10.7% stroke , 5.6% hip fracture , and 11.9% had high depressive symptoms at baseline . \\n the prevalence of participants who fell once was 16.6% and was 14.7% for those who fell two or more times . \\n the mean mmse score was 25.53.1 for no falls , 24.93.0 for one fall , and 24.52.9 for two or more falls . \\n the difference was statistically significant between those who fell two or more times and those who did not fall ( p<0.05 ) . \\n participants who fell two or more times were significantly more likely to be older , female , and to report higher levels of depressive symptoms , hypertension , diabetes , heart attack , and stroke compared to those with one fall or no falls . \\n no statistically significant association was seen with hip fracture . those who fell two or more times had lower performance in handgrip strength when compared with those with no falls ( p<0.05 ) . \\n table 2 shows the general linear mixed model estimates for mmse score as a function of fall over a 6-year period \\n . the adjusted rate of decline in the total mmse score was 0.25 points per year ( model 1 ) . \\n participants who fell two or more times had a greater decline in mmse score of 0.81 points per year ( p<0.0001 ) compared with those who did not fall , after adjusting for age , sex , marital status , and education ( model 1 ) . \\n participants who fell one time had a decline in mmse score of 0.14 points per year compared to the those who did not fall , but this difference was not statistically significant ( p=0.4261 ) . in model 2 , \\n when high depressive symptoms was added to all variables in model 1 , the association between two or more falls decreased but remained statistically significant ( estimate = 0.64 , standard error = 0.19 , p=0.0007 ) : a decline of 0.64 points per year compared with those who did not fall . in model 3 , after adding medical conditions and hand grip muscle strength to model 2 , the association between two or more falls and mmse score remained statistically significant ( estimate = 0.46 , standard error = 0.19 , p=0.0161 ) : a decline of 0.46 points per year compared with those who did not fall . \\n female sex , high level of education , and high performance in hand grip muscle strength were associated with a lower decline in mmse scores . \\n figures 1 and 2 shows the unadjusted and adjusted mean distribution for the total mmse score over the 6-year period by falls status . \\n participants with two or more falls had lower total mmse scores than subjects with one fall or no falls over the follow - up period . \\n we also found that , among a cohort of cognitively normal elders , those with history of recurrent falls experienced a greater decline in their cognitive function over a 6-year period compared to those with no history of falls . \\n the fall  cognitive - decline association was independent of age , sex , marital status , and education . \\n presence of high depressive symptoms partially mediated the relationship between falls and cognitive decline . as expected , and consistent with prior studies , a high level of education and high performance in hand grip muscle strength \\n our findings are similar to prior studies and different from others.912,3335 most studies have looked at the falls  cognition association from the perspective of falls - related brain injury versus no injury as predictors of cognitive decline.3335 others have studied risks and consequences of falls in the dementia population , or gait disorders as predictors of cognitive decline or dementia , mostly in non - hispanic populations.36,37 ours is the first study to show that recurrent falls independently predict future cognitive decline in a cohort of community - dwelling hispanic elders with normal baseline cognitive measure . \\n it is not clear how recurrent falls predict cognitive decline , but one possibility is a shared risk factor for both falls and cognitive decline ( eg , strokes , shared brain network for cognition and gait control , low vitamin d , and brain amyloids).3841 for example , low vitamin d levels are associated with falls , depression , and cognitive impairments.38,39 a 12-month prospective cohort study of cognitively normal , community - dwelling older adults ( n=125 , mean age = 75 years ) showed that higher levels of brain amyloid ( pittsburgh compound b retention ) and of cerebrospinal fluid tau / a42 biomarker ratios were significantly associated with increased risk of falls.42 these amyloid imaging markers have been well described in persons with mild cognitive impairment and dementia.43,44 lack of amyloid imaging data precludes us from testing the association between amyloid burden and recurrent falls in our subjects with incident cognitive decline . \\n this is an important area for further study , using a combination of amyloid imaging and cerebrospinal fluid biomarker . \\n were such an association proven , recurrent falls might alert clinicians to patients with high risk of future dementia . \\n the literature supports our findings of an association of falls with depressive symptoms and subsequent cognitive decline.1422,45 a 12-year longitudinal study of 2,425 cognitively intact adults showed that high depressive symptoms were associated with accelerated decline in memory , compared to low depressive symptoms as measured with the center for epidemiologic studies depression scale.45 this association suggests that older adults who fall should be monitored for depression . \\n another possible explanation for falls  cognitive - decline association is that recurrent fallers are simply sicker than non - fallers , with more conditions ( eg , diabetes , heart attacks ) that contribute to the mmse decline seen in recurrent fallers . \\n our study indicated that recurrent fallers at baseline were more likely than non - fallers to have lower handgrip muscle strength , hypertension , diabetes , heart attacks , and stroke . \\n our findings linking falls to cognitive decline still remained significant after adjustment for these conditions . \\n clearly , efforts to prevent falls - related disabilities require multidimensional approaches to address not just multiple risk factors , but also cognitive , physical , and emotional consequences of falls . \\n the world alzheimer report states that the earlier the diagnosis of dementia , the better the patients outcome.46 since falls appear to be a predictor of subsequent cognitive decline , health care professionals may be able to detect patients at risk for dementia and implement preventive strategies . \\n possibilities of such strategies include , but are not limited to , physical activity , mediterranean diet , and smoking cessation.6,21,26,43,46 clinically , our study also suggests that those who fell , even if cognitively intact , should be screened over time not only for cognitive impairment , but also for emergence of depressive symptomatology , with the expectation that such screening will trigger timely interventions to improve psychological health and reduce future falls . \\n depression in fallers could be caused by a fear of having another fall , a syndrome that may be amenable to interventions . \\n after a first fall , the fear of falling increases and could cause an adult to withdraw from activities as a defense against future falls . \\n this activity restriction may manifest as depression.1720 depression is thought to increase the likelihood of cognitive decline.10,11,47 however , caution should be used while prescribing antidepressants to patients who have fallen as studies have shown that these medications cause an increased risk in falling equal to that of untreated depression.16,48 nonpharmacological treatment of these patients may be the most effective option.16 our study has several limitations . \\n generalizability of our findings to other populations is limited because of the low educational attainment ( mean years = 6.3 ) and advanced age ( mean age = 80.8 years ) of our subjects . \\n the h - epese data for falls and comorbidities were self - reported , raising the possibility of recall bias , especially if participants have impaired cognition . \\n . we also could not confirm participant self - reports of medical conditions because of unavailability of participants medical records , radiologic imaging , and blood tests . \\n however , recent studies have validated the reliability of self - reports in studies on fears of falling in cognitively intact and impaired older adults and on barriers to mobility after stroke.49,50 the mmse is used primarily as a screening assessment for cognitive function and has limited sensitivity to detect changes over time , particularly in specialized areas of cognition . \\n thus , the rate of cognitive decline in our study may tend towards an underestimation . \\n our study has several strengths : large community - based sample , prospective design , and exploration of the potential role of falls and depression in cognitive disablement in older mexican americans ( a rapidly growing segment of us elderly population ) . \\n another important strength of our study is the use of mixed models , an analytic approach that allowed the use of all available data and evaluation of time - dependent effects . \\n in conclusion , having recurrent falls was independently associated with steeper decline in cognition over 6 years compared to having no history of falls , with a mediating effect of depression on the association between falls and cognitive decline . \\n the findings suggest that screening for cognitive and emotional problems in recurrent fallers might help stem the onset of falls - related physical and cognitive disability . \\n future studies should explore the best way to screen for and treat depression and fear of falling in older adults who have fallen .', 'output': 'backgroundlittle is known about long - term emotional and cognitive consequences of falls . \\n we examined the association between falls and subsequent cognitive decline , and tested the hypothesis that depression would mediate any falls \\n cognition association among cognitively intact hispanic elders.methodswe used data from the hispanic established population for the epidemiological study of the elderly to examine change in mini mental state examination ( mmse ) scores over the 6-year period according to number of falls . \\n all participants ( n=1,119 ) had mmse scores 21 and complete data on center for epidemiologic studies of depression scale , social and demographic factors , medical conditions ( diabetes , heart attack , stroke , and hypertension ) , and hand grip muscle strength.resultsat baseline , participants mean age was 80.8 years ( range , 74109 ) , mean education was 6.3 years ( range , 017 ) , and mean mmse was 25.2 ( range , 2130 ) . of the 1,119 participants , 15.8% experienced one fall and 14.4% had two or more falls . in mixed model analyses , having two or more falls was associated with greater decline in mmse score ( estimate = 0.81 , standard error = 0.19 , p<0.0001 ) compared to having no fall , after adjusting for age , sex , marital status , and education . \\n the magnitude of the association decreased ( estimate = 0.65 , standard error = 0.19 , p=0.0007 ) when adjustment was made for high depressive symptoms , suggesting a possible mediating effect of depression on the falls  cognition association . \\n female sex , high level of education , and high performance in hand grip muscle strength were associated with a slower decline in mmse scores.conclusionhaving two or more falls was independently associated with steeper decline in cognition over 6 years , with a possible mediating effect of depression on the falls  cognition association .', '__index_level_0__': 30448}\n",
      "Task: nli, Sampled: 50\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Acromegaly is associated with cardiac hypertrophy, which is believed to be a direct consequence of chronically elevated GH and IGF1. Given that insulin is important for cardiac growth and function, and considering that GH excess induces hyperinsulinemia, insulin resistance, and cardiac alterations, it is of interest to study insulin sensitivity in this tissue under chronic conditions of elevated GH. Transgenic mice overexpressing GH present cardiomegaly and perivascular and interstitial fibrosis in the heart. Mice received an insulin injection, the heart was removed after 2\\u200a min, and immunoblotting assays of tissue extracts were performed to evaluate the activation and abundance of insulin-signaling mediators. Insulin-induced tyrosine phosphorylation of the insulin receptor (IR) was conserved in transgenic mice, but the phosphorylation of IR substrate 1 (IRS1), its association with the regulatory subunit of the phosphatidylinositol 3-kinase (PI3K), and the phosphorylation of AKT were decreased. In addition, total content of the glucose transporter GLUT4 was reduced in transgenic mice. Insulin failed to induce the phosphorylation of the mammalian target of rapamycin (mTOR). However, transgenic mice displayed increased basal activation of the IR/IRS1/PI3K/AKT/mTOR and p38 signaling pathways along with higher serine phosphorylation of IRS1, which is recognized as an inhibitory modification.', 'output': 'contradiction', '__index_level_0__': 29537}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Renal tubular epithelial cell (RTC) apoptosis causes tubular atrophy, a hallmark of renal disease progression. Apoptosis is generally characterized by reduced cell volume and cytosolic pH, but epithelial cells are relatively resistant to shrinkage due to regulatory volume increase, which is mediated by Na(+)/H(+) exchanger (NHE) 1. We investigated whether RTC apoptosis requires caspase cleavage of NHE1. Staurosporine- and hypertonic NaCl-induced RTC apoptosis was associated with cell shrinkage and diminished cytosolic pH, and apoptosis was potentiated by amiloride analogs, suggesting NHE1 activity opposes apoptosis. NHE1-deficient fibroblasts demonstrated increased susceptibility to apoptosis, which was reversed by NHE1 reconstitution. NHE1 expression was markedly decreased in apoptotic RTC due to degradation, and preincubation with peptide caspase antagonists restored NHE1 expression, indicating that NHE1 is degraded by caspases. Recombinant caspase-3 cleaved the in vitro-translated NHE1 cytoplasmic domain into five distinct peptides, identical in molecular weight to NHE1 degradation products derived from staurosporine-stimulated RTC lysates. In vivo, NHE1 loss-of-function C57BL/6.SJL-swe/swe mice with adriamycin-induced nephropathy demonstrated increased RTC apoptosis compared with adriamycin-treated wild-type controls, thereby implicating NHE1 inactivation as a potential mechanism of tubular atrophy.', 'output': 'contradiction', '__index_level_0__': 29540}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Combination therapy with epidermal growth factor (EGF) and gastrin induces beta-cell regeneration in rodents with chemically induced diabetes. We investigated whether EGF plus gastrin could correct hyperglycemia in NOD mice with autoimmune diabetes. Combined treatment with EGF (1 mug/kg) and gastrin (3 mug/kg) for 2 weeks restored normoglycemia after diabetes onset in NOD mice, whereas EGF or gastrin alone did not. Fasting blood glucose remained normal (3.5-6.5 mmol/l) or mildly elevated (<11 mmol/l) in five of six mice (83%) for 10 weeks after EGF plus gastrin treatment was stopped, whereas all mice treated with vehicle or EGF or gastrin alone became severely hyperglycemic (12-35 mmol/l). Pancreatic beta-cell mass was increased threefold and insulin content was increased eightfold in mice treated with EGF plus gastrin compared with pretreatment values. The correction of hyperglycemia correlated significantly with increases in pancreatic beta-cell mass and insulin content. In addition, splenic cells from mice treated with EGF plus gastrin delayed diabetes induction by adoptive transfer of diabetogenic cells into immunodeficient NOD-scid mice, suggesting the induction of immunoregulatory cells in NOD mice treated with EGF plus gastrin.', 'output': 'contradiction', '__index_level_0__': 29536}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Fibroblast growth factor 21 (FGF21)-mediated weight loss and improvements in glucose metabolism correlate with increased uncoupling protein 1 (Ucp1) levels in adipose tissues, suggesting that UCP1-dependent thermogenesis may drive FGF21 action. It was reported that FGF21 is equally effective at reducing body weight and improving glucose homeostasis without UCP1. We find while FGF21 can lower body weight in both wild-type and Ucp1 knockout mice, rapid clearance of glucose by FGF21 is defective in the absence of UCP1. Furthermore, in obese wild-type mice there is a fall in brown adipose tissue (BAT) temperature during glucose excursion, and FGF21 improves glucose clearance while preventing the fall in BAT temperature. In Ucp1 knockout mice, the fall in BAT temperature during glucose excursion and FGF21-mediated changes in BAT temperature are lost.', 'output': 'entailment', '__index_level_0__': 29472}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Plasma free fatty acids are elevated in patients with type 2 diabetes and contribute to the pathogenesis of insulin resistance and endothelial dysfunction. The p38 MAPK mediates stress, inflammation, and apoptosis. Whether free fatty acids induce apoptosis and/or activate nuclear factor-kappaB inflammatory pathway in human coronary artery endothelial cells (hCAECs) and, if so, whether this involves the p38 MAPK pathway is unknown. hCAECs (passages 4-6) were grown to 70% confluence and then incubated with palmitate at concentrations of 0-300 microm for 6-48 h. Palmitate at 100, 200, or 300 microm markedly increased apoptosis after 12 h of incubation. This apoptotic effect was time (P=0.008) and dose (P=0.006) dependent. Palmitate (100 microm for 24 h) induced a greater than 2-fold increase in apoptosis, which was accompanied with a 4-fold increase in p38 MAPK activity (P<0.001). Palmitate did not affect the phosphorylation of Akt1 or ERK1/2. SB203580 (a specific inhibitor of p38 MAPK) alone did not affect cellular apoptosis; however, it abolished palmitate-induced apoptosis and p38 MAPK activation. Palmitate significantly reduced the level of inhibitor of nuclear factor-kappaB (IkappaB). However, treatment of cells with SB203580 did not restore IkappaB to baseline.', 'output': 'entailment', '__index_level_0__': 29507}\n",
      "Task: generation, Sampled: 50\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hi doctor,I pee very often (even though I am young and I do not have diabetes or anything), and I get horn whenever my bladder is full. I do not think it as a healthy habit, and it disturbs me. Please help me.', 'output': 'Hi, Welcome to Chat Doctor forum. You should rule out the cause for frequent urination. It can be due to urinary tract infection and due to impaired sugar control. If you have a burning sensation or feeling urgency to void the bladder, it indicates an infection. So, get your urine test done along with fasting blood sugar. It is not abnormal to have an erotic feeling while the bladder is full. The sensations produced by stretching of the bladder wall may give some erotic sensation.', '__index_level_0__': 29801}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hi doctor,I am a 58 year old female. I am suffering from both blood pressure and diabetes. I was diagnosed with endometrial cancer and undergone hysterectomy. I have also attached my reports. Please guide me.', 'output': 'Hello. I had verified your report (attachment removed to protect patient identity) and I must say that you have undergone hysterectomy which is the best-known treatment for grade 2 endometrial cancer. I advise you to consult your doctor regularly even after surgery and do not forget to take adjuvant therapy which is very important to prevent cancer in the future. For blood pressure and diabetes, I hope you will control them with medication and lifestyle changes.', '__index_level_0__': 29745}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hello doctor,Four months ago, I consulted you on this platform for premature complexes which I was having without any other symptoms. Below is my query and your answer - I am a male of 48 years of age. I have a lean build and do regular exercise. Since childhood, I had a tendency for heart palpitations and premature beats. After a few tests, anxiety was found to be the main cause.  You had said that most probably these premature complexes are originating from ventricles which are leading to the symptoms. These are usually benign and not life threatening. The only concern remains is that of coronary artery disease, which is also less likely as these are occurring from a long time and you are not having any other symptoms. Lack of sleep, stress, alcohol, smoking, caffeinated beverages are known triggering factors for these due to sympathetic overactivity. You should also get thyroid test done. I think, just be on a safer side, you should get one treadmill test done to rule out coronary artery disease and echo should be repeated. Afterwards, I met a cardiologist and got an ECG and echo tests done. The tests were normal. The cardiologist said that there is no need for TMT test since I do running and other exercises daily and there is no known risk factor for CAD. But the VPCs continued for a month.Then, I realized that I was taking a weight gainer supplement from the last one year which contained creatinine. Two months back, I was not doing any exercise due to a small fracture in my elbow but continued to take this supplement. The doctor advised me to stop the supplement immediately since this could be the cause of missed beats. Then I read in the internet and found out that there have been cases of irregular heart beats due to creatinine supplementation. I stopped taking the supplement although it was from a reputed firm and did not contain any steroids. The missed beats reduced after stopping the supplement and from the last two months, it has come to a normal level of one or two in a day. But somehow my mind started getting preoccupied with the thoughts of heart disease and I started reading about it from the internet and even textbooks.I have been thin and slim since my childhood, have been quite active physically, no family history of heart disease, no diabetes, no hypertension, non-smoker, rarely eat fried foods. My lipid profile is normal with HDL being about 55 whenever tested, CRP is around 0.5. But in spite of this, I was not able to free my mind from worries of CAD. A month back, I did quite a lot of pushups after a gap of four to five months. After three to four days, I started having pain in my chest here and there mostly at rest. After a week I got an ECG done which was normal. The pain subsided slowly but whenever I did some exercise which put a strain on the chest muscle I started having pain and with pain, more worries.Then I met a psychiatrist. He said that I have got into an obsessive loop, which is part of health anxiety disorder which is causing these psychosomatic symptoms of chest pain. He advised me to take some antidepressants for three months, do Yoga and meditation and take some sessions of cognitive behavior therapy. I am reluctant to take antidepressants but have already started doing some meditation and Yoga. He also prescribed Alprazolam .25 mg on SOS basis. Now the pain is subsiding slowly and obsessive thoughts are also reducing. I have stopped doing any exercise that would put a strain on the chest. I do not know how long it will take to resume it. In a recent blood test, two months back my vitamin D3 was at 28. Could it be the cause of the chest pain? Secondly, I stopped the supplement but continued some strenuous exercises without taking a proper diet. Could it be the cause of it? Please guide me. How to get rid of this unwanted health anxiety which I have got into?', 'output': 'Hello. Looking at the overall picture, the problem appears to be a minor one and not worrisome. All the best. For more information consult a cardiologist online', '__index_level_0__': 29800}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hi doctor,My mother got a sudden heart pain. I took her to the hospital. After ECG And further processing, we came to know that she got ischemic heart disease and her two valves of the heart are closed. She has diabetes and blood pressure problems due to which atherosclerosis occurred three days ago. The doctor told him for angiography. Are angiography and stent good for her? Please also tell me about everything related to heart problems cure and heart diet.', 'output': 'Hi, Welcome to Chat Doctor forum. An angiogram has to be done in your mother\\\\\\\\s case to know the extent of the blocks. Also, since she has blocked valves as you said, open heart surgery and valve replacement will be an option for her rather than stenting. In terms of diet to prevent heart disease, it is useful to avoid excess fried foods and red meat. Lean meat like chicken and fish are beneficial. Cook food in oils like sunflower oil or groundnut oil rather than coconut oil. If she is diabetic, make sure the diabetic control is strict. For more information consult a cardiologist online', '__index_level_0__': 29774}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hi doctor,Recently, I had undergone chest X-ray, ECG, creatinine, fasting glucose, postprandial blood sugar, urea, uric acid, lipid profile, liver function test, thyroid stimulating hormone, TSH, urine complete analysis, complete blood count with ESR and ultrasound of abdomen and pelvis. All the reports came back normal except my urine report. My chemical examination of urine says there is blood in the urine and the microscopic examination says pus cells and RBCs are present. I contacted my doctor immediately and he suggested to go for urine culture and sensitivity. The report came after three days and it looks normal as well. It says, no growth noticed at the end of 48 hours of incubation and microscopic examination says occasional pus cells and no microorganisms were seen. The doctor said not to worry and that everything is alright. He suggested taking more water. He also mentioned that the ultrasound report is also normal. I searched on the internet about RBCs in the blood and saw some very strange articles which scared me a lot. I request you to kindly help me out and suggest what I should do.', 'output': 'Hello, Welcome to Chat Doctor forum. According to your reports, it seems to be a urinary tract infection secondary to a kidney stone. Some kidney stones are not visible on the ultrasound. So, I suggest you do a CT scan of the abdomen and repeat urinalysis. If the same report persists, then we can think of nephrolithiasis. Such reports can be seen in acute kidney injury secondary to a urinary tract infection which usually subsides on its own. Do not worry. For more information consult an internal medicine physician online', '__index_level_0__': 29798}\n",
      "Task: qa_objective_2, Sampled: 50\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 48-year-old man presents to a physician with complaints of paresthesia of the lower extremities, which he has had for the last 3 months. He has been frequently fatigued for the past 5 months and also experienced an increased frequency of urination over the last few months. There is no history of a known medical condition or of substance abuse. His physical examination does not reveal any specific abnormality, except that he is obese: his body mass index is 34.6 kg/m2. The patientâ€™s detailed laboratory evaluation reveals a fasting plasma glucose of 160 mg/dL and 2-hour plasma glucose of 270 mg/dL. His physician tells him that his laboratory evaluation suggests a diagnosis of diabetes mellitus type 2. The patient, surprised by this news, asks his physician why he has developed diabetes mellitus even though no one else in his family has ever suffered from it. The physician explains to him that genetic factors play an important role in the development of diabetes mellitus, but that their interactions are complex. Apart from neonatal diabetes mellitus and maturity-onset diabetes of the young (MODY), the development of diabetes mellitus cannot be explained by a single genetic mutation. Which of the following options best explains the genetics of the form of diabetes mellitus from which this man is suffering? Please select one of the following: A) Genomic imprinting, B) Natural selection, C) Polygenic inheritance, D) Synergistic epistasis.', 'output': 'C) Polygenic inheritance', '__index_level_0__': 30041}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 59-year-old man is evaluated for progressive joint pain. There is swelling and tenderness over the first, second, and third metacarpophalangeal joints of both hands. His hand radiograph shows beak-like osteophytes on his 2nd and 3rd metacarpophalangeal joints, subchondral cysts, and osteopenia. He has had diabetes mellitus for 2 years which is not well controlled with medications. Lab studies show a transferrin saturation of 88% and serum ferritin of 1,200 ng/mL. This patient is at risk of which of the following complications? Please select one of the following: A) Hypogonadism, B) Hepatic adenoma, C) Hypertrophic cardiomyopathy, D) Hepatic steatosis.', 'output': 'A) Hypogonadism', '__index_level_0__': 30010}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': \"A 23-year-old man is brought to the emergency department by ambulance. The patient was found unconscious in his bedroom after a suicide attempt. The patient had cut his wrists using a kitchen knife. The patient is unresponsive and pale. His temperature is 96Â°F (35.6Â°C), blood pressure is 70/35 mmHg, pulse is 190/min, respirations are 19/min, and oxygen saturation is 92% on room air. Pressure is applied to his bilateral wrist lacerations. His Glasgow Coma Scale (GCS) is 7. A full trauma assessment is performed and reveals no other injuries. IV fluids are started as well as a rapid transfusion sequence. Norepinephrine is administered. Repeat vitals demonstrate that his blood pressure is 100/65 mmHg and pulse is 100/min. The patient is responsive and seems mildly confused. Resuscitation is continued and the patient's GCS improves to 15. Thirty minutes later, the patient's GCS is 11. His temperature is 103Â°F (39.4Â°C), blood pressure is 90/60 mmHg, pulse is 122/min, respirations are 22/min, and oxygen saturation is 99% on room air. The patient complains of flank pain. Laboratory values are ordered and demonstrate the following:\\n\\nHemoglobin: 9 g/dL\\nHematocrit: 27%\\nLeukocyte count: 10,500 cells/mm^3 with normal differential\\nHaptoglobin: 11 mg/dL\\nPlatelet count: 198,000/mm^3\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 101 mEq/L\\nK+: 4.4 mEq/L\\nHCO3-: 23 mEq/L\\nBUN: 27 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 1.5 mg/dL\\nCa2+: 10.0 mg/dL\\nBilirubin: 3.2 mg/dL\\nAST: 22 U/L\\nALT: 15 U/L\\n\\nWhich of the following describes the most likely diagnosis? Please select one of the following: A) Non-cardiogenic acute lung injury, B) Decreased IgA levels, C) Major blood group incompatibility, D) Minor blood group incompatibility.\", 'output': 'C) Major blood group incompatibility', '__index_level_0__': 30073}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A previously healthy 5-year-old boy is brought to the emergency department because of a 1-day history of high fever. His temperature prior to arrival was 40.0Â°C (104Â°F). There is no family history of serious illness. Development has been appropriate for his age. He is administered rectal acetaminophen. While in the waiting room, he becomes unresponsive and starts jerking his arms and legs back and forth. A fingerstick blood glucose concentration is 86 mg/dL. After 5 minutes, he continues having jerky movements and is unresponsive to verbal and painful stimuli. Which of the following is the most appropriate next step in management? Please select one of the following: A) Intravenous administration of lorazepam, B) Intravenous administration of phenobarbital, C) Obtain blood cultures, D) Intravenous administration of fosphenytoin.', 'output': 'A) Intravenous administration of lorazepam', '__index_level_0__': 30122}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 63-year-old man comes to the physician for the evaluation of a skin lesion on his chest. He first noticed the lesion 2 months ago and thinks that it has increased in size since then. The lesion is not painful or pruritic. He has type 2 diabetes mellitus, hypercholesterolemia, and glaucoma. The patient has smoked 1 pack of cigarettes daily for the last 40 years and drinks two to three beers on the weekend. Current medications include metformin, atorvastatin, topical timolol, and a multivitamin. Vital signs are within normal limits. The lesion is partly elevated on palpation and does not change its form on pinching. A photograph of the lesion is shown. Which of the following is the most likely diagnosis? Please select one of the following: A) Malignant melanoma, B) Keratoacanthoma, C) Lentigo maligna, D) Basal cell carcinoma.', 'output': 'A) Malignant melanoma', '__index_level_0__': 30028}\n"
     ]
    }
   ],
   "source": [
    "import random\n",
    "import numpy as np\n",
    "import pandas as pd  # pandas ìž„í¬íŠ¸ ì¶”ê°€\n",
    "from datasets import load_dataset, Dataset, DatasetDict\n",
    "\n",
    "# ì‹œë“œ ê°’ ì„¤ì •\n",
    "SEED = 42\n",
    "\n",
    "# Pythonì˜ random ëª¨ë“ˆ ì‹œë“œ ê³ ì •\n",
    "random.seed(SEED)\n",
    "\n",
    "# NumPy ì‹œë“œ ê³ ì •\n",
    "np.random.seed(SEED)\n",
    "\n",
    "# 1. ë°ì´í„°ì…‹ ë¡œë“œ\n",
    "dataset_name = \"passionMan/diabetes_v7\"\n",
    "train_dataset = load_dataset(dataset_name, split=\"train\")\n",
    "test_dataset = load_dataset(dataset_name, split=\"test\")\n",
    "\n",
    "# 2. ì¤‘ë³µ í™•ì¸ì„ ìœ„í•œ train ë°ì´í„°ì˜ (input, output) ì„¸íŠ¸ ìƒì„±\n",
    "train_pairs = set((row[\"input\"], row[\"output\"]) for row in train_dataset)\n",
    "\n",
    "# 3. ê° taskë³„ ìƒ˜í”Œ ê°œìˆ˜ ì„¤ì •\n",
    "task_sample_limits = {\n",
    "    'qa_objective_1': 50,\n",
    "    'qa_objective_2': 50,\n",
    "    'qa_objective_3': 50,\n",
    "    'nli': 50,\n",
    "    'ie_extract_relation': 50,\n",
    "    \"summarization\": 50,\n",
    "    \"generation\": 50,\n",
    "    'alternative_diet': 50,\n",
    "    'daily_diets': 50,\n",
    "}\n",
    "default_sample_limit = 50  # ë‚˜ë¨¸ì§€ taskëŠ” 100ê°œì”© ìƒ˜í”Œë§\n",
    "\n",
    "# 4. taskë³„ ìƒ˜í”Œë§ ë°ì´í„° ì´ˆê¸°í™”\n",
    "task_sampled_data = {}\n",
    "# task_countsë¥¼ task_sample_limitsë¡œ ì´ˆê¸°í™”\n",
    "task_counts = {task: 0 for task in task_sample_limits}\n",
    "\n",
    "# 5. Taskë³„ ìƒ˜í”Œë§\n",
    "# í…ŒìŠ¤íŠ¸ ë°ì´í„°ì…‹ì„ ì…”í”Œë§í•˜ì—¬ ëžœë¤ ìƒ˜í”Œë§ ë³´ìž¥\n",
    "test_dataset = test_dataset.shuffle(seed=SEED)\n",
    "\n",
    "for row in test_dataset:\n",
    "    task = row[\"task\"]\n",
    "    dataset_value = row.get(\"dataset\")  # dataset ì»¬ëŸ¼ ê°’ í™•ì¸\n",
    "    input_output_pair = (row[\"input\"], row[\"output\"])\n",
    "\n",
    "    # qa_objective ì„¸ë¶„í™”\n",
    "    if task == \"qa_objective\":\n",
    "        if dataset_value == \"medqa\":\n",
    "            task = \"qa_objective_2\"  # medqaë¡œ ì„¸ë¶„í™”\n",
    "        elif dataset_value == \"medmcqa\":\n",
    "            task = \"qa_objective_2\"  # medmcqaë¡œ ì„¸ë¶„í™”\n",
    "        else:\n",
    "            continue  # medqa, medmcqaê°€ ì•„ë‹ˆë©´ ê±´ë„ˆë›°ê¸°\n",
    "\n",
    "    # í•´ë‹¹ taskì˜ ìƒ˜í”Œë§ ì œí•œ í™•ì¸\n",
    "    sample_limit = task_sample_limits.get(task, default_sample_limit)\n",
    "\n",
    "    # ìƒ˜í”Œë§ ì¡°ê±´ í™•ì¸\n",
    "    if task_counts.get(task, 0) < sample_limit and input_output_pair not in train_pairs:\n",
    "        if task not in task_sampled_data:\n",
    "            task_sampled_data[task] = []\n",
    "        task_sampled_data[task].append(row)\n",
    "        task_counts[task] += 1\n",
    "\n",
    "    # ëª¨ë“  taskì˜ ìƒ˜í”Œë§ì´ ì™„ë£Œë˜ë©´ ì¢…ë£Œ\n",
    "    if all(task_counts.get(task, 0) >= task_sample_limits.get(task, default_sample_limit) for task in task_sample_limits):\n",
    "        break\n",
    "\n",
    "# 6. ê²°ê³¼ ì¶œë ¥ ë° í™•ì¸\n",
    "for task, samples in task_sampled_data.items():\n",
    "    print(f\"Task: {task}, Sampled: {len(samples)}\")\n",
    "    for sample in samples[:5]:  # ì²« 5ê°œ ìƒ˜í”Œë§Œ ì¶œë ¥\n",
    "        print(sample)\n",
    "\n",
    "# 7. í•„ìš” ì‹œ ìƒ˜í”Œë§ëœ ë°ì´í„° ì €ìž¥\n",
    "# pandasë¥¼ ì‚¬ìš©í•˜ì—¬ ë¦¬ìŠ¤íŠ¸ì˜ ë”•ì…”ë„ˆë¦¬ë¥¼ ë°ì´í„°í”„ë ˆìž„ìœ¼ë¡œ ë³€í™˜ í›„ Datasetìœ¼ë¡œ ë³€í™˜\n",
    "sampled_dataset = DatasetDict({\n",
    "    task: Dataset.from_pandas(pd.DataFrame(samples)) for task, samples in task_sampled_data.items()\n",
    "})\n",
    "\n",
    "# ì €ìž¥ (í•„ìš”ì‹œ ì£¼ì„ ì œê±°)\n",
    "# sampled_dataset.save_to_disk(\"sampled_test_dataset\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing samples: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 450/450 [2:32:33<00:00, 20.34s/sample]    \n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "import re\n",
    "from tqdm import tqdm\n",
    "from transformers import TextStreamer\n",
    "\n",
    "FastLanguageModel.for_inference(model)\n",
    "\n",
    "output_file = \"inference_results_0127.jsonl\"\n",
    "\n",
    "# 1. `tqdm`ì„ ì‚¬ìš©í•˜ì—¬ ì§„í–‰ ìƒíƒœ í‘œì‹œ\n",
    "total_samples = sum(len(samples) for samples in sampled_dataset.values())\n",
    "with open(output_file, 'w') as f_out:\n",
    "    with tqdm(total=total_samples, desc=\"Processing samples\", unit=\"sample\") as pbar:\n",
    "        for task, sample in sampled_dataset.items():\n",
    "            for samp in sample:\n",
    "                # ë°ì´í„°ì…‹ ì´ë¦„ì— ë”°ë¥¸ context length ì„¤ì •\n",
    "                dataset_name = samp.get(\"dataset\", \"\")\n",
    "                max_new_tokens = 8192 if dataset_name in [\"pubmedqa\", \"pubmed\", \"icliniq\"] else 2048\n",
    "\n",
    "                # ìž…ë ¥ í† í° ìƒì„±\n",
    "                inputs = tokenizer(\n",
    "                    [\n",
    "                        alpaca_prompt.format(\n",
    "                            samp['instruction'],  # instruction\n",
    "                            samp['input'],  # input\n",
    "                            \"\",  # output\n",
    "                        )\n",
    "                    ], return_tensors=\"pt\"\n",
    "                ).to(\"cuda\")\n",
    "\n",
    "                # TextStreamer ì„¤ì •\n",
    "                text_streamer = TextStreamer(tokenizer)\n",
    "                \n",
    "                # ëª¨ë¸ ìƒì„± ë° ì¶œë ¥\n",
    "                output_tensor = model.generate(\n",
    "                    **inputs, \n",
    "                    max_new_tokens=max_new_tokens\n",
    "                )\n",
    "                model_output = tokenizer.decode(output_tensor[0], skip_special_tokens=True)\n",
    "\n",
    "                # `### Response:` ë’¤ì˜ í…ìŠ¤íŠ¸ ì¶”ì¶œ\n",
    "                response_text = None\n",
    "                response_match = re.search(r\"### Response:\\s*(.+)\", model_output, re.DOTALL)\n",
    "                if response_match:\n",
    "                    response_text = response_match.group(1).strip()\n",
    "                else:\n",
    "                    response_text = \"No valid response found\"\n",
    "\n",
    "                # ëª¨ë¸ ì¶œë ¥ ê²°ê³¼ë¥¼ sampì— ì¶”ê°€\n",
    "                samp['model_output'] = response_text\n",
    "\n",
    "                # JSONL í˜•ì‹ìœ¼ë¡œ ì €ìž¥\n",
    "                f_out.write(json.dumps(samp, ensure_ascii=False) + \"\\n\")\n",
    "                \n",
    "                # tqdm ì§„í–‰ ìƒíƒœ ì—…ë°ì´íŠ¸\n",
    "                pbar.update(1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "meal_kernel",
   "language": "python",
   "name": "meal"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
